TSS:Hg 111138.1

Basic information about the TSS

---

TSS ID: hg_111138.1 Species: human Chr: chr10		Start: 102120557 End: 102120572 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000673968.1 Distance: 190 GeneID: 8861 HGNC/MGI_ID: HGNC:6532 UniProt_ID: Q86U70

Gene_name: LIM domain binding 1 Gene_symbol: LDB1 Gene_synonyms: CLIM2 NLI Gene_source: HGNC:6532

TATA-Box annotation

---

Distance to TSS:	-92
Nearest PromoterID:	NM_001113407
Entrez ID:	8861
Nearest Unigene:	Hs.454418
Nearest Refseq:	NM_003893
Nearest Ensembl:	ENSG00000198728
Gene Name:	LIM domain binding 1
Gene Alias:	CLIM-2|CLIM2|LDB-1|NLI
Gene Description:	LIM domain binding 1
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.706468
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LDB1 p2@LDB1 p3@LDB1 p4@LDB1 p5@LDB1 p6@LDB1 p7@LDB1 p8@LDB1 p9@LDB1
Sample		p1@LDB1	p2@LDB1	p3@LDB1	p4@LDB1	p5@LDB1	p6@LDB1	p7@LDB1	p8@LDB1	p9@LDB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.84	4.68	2.92	0.78	1.36	1.56	0.00	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.69	3.64	3.64	0.20	1.01	1.01	0.40	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.14	5.98	3.28	0.58	0.77	0.58	0.19	0.58	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.32	6.24	2.49	0.83	1.25	1.25	0.00	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.50	6.52	2.47	0.22	2.25	1.80	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.78	5.62	3.49	0.19	3.10	1.36	0.19	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.42	4.58	3.92	0.44	2.61	0.87	0.44	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.45	4.12	3.88	0.73	2.18	2.18	0.73	0.00	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.47	4.06	3.21	0.43	2.35	1.28	0.21	0.43	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.11	3.48	5.80	0.00	2.90	0.58	0.58	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.11	7.68	4.85	0.81	1.62	0.81	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.94	5.69	5.69	1.22	2.44	0.81	0.81	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	46.10	6.13	13.22	2.42	7.09	1.61	1.29	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	42.85	5.56	9.32	1.65	7.82	2.56	0.90	0.75	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.47	5.93	13.61	2.63	8.56	2.42	1.54	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	37.22	4.78	7.54	0.50	6.79	1.51	1.26	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	37.13	5.24	6.12	1.97	3.71	0.87	0.00	1.53	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.12	6.33	2.95	1.69	6.33	2.11	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	41.05	6.93	4.27	1.60	7.46	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	39.11	5.12	9.03	2.11	5.42	1.20	0.90	0.90	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	38.36	5.48	10.69	2.27	5.88	1.60	0.40	0.80	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	43.85	5.18	8.98	1.55	6.21	0.69	0.69	1.21	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.48	6.72	7.11	1.68	6.59	1.94	1.16	0.78	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.25	8.01	9.22	1.70	5.82	1.94	1.21	0.73	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	51.08	6.45	7.22	2.32	7.74	1.29	1.29	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	53.81	4.43	6.33	4.11	7.60	0.63	0.95	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.66	6.04	5.49	1.65	8.79	1.10	1.65	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	47.39	5.89	9.43	2.59	9.19	1.41	2.36	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.35	3.23	8.56	2.26	4.68	1.13	1.13	0.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.18	6.70	7.24	1.99	4.52	2.17	0.90	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.57	2.51	5.65	1.88	7.75	0.21	0.84	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	41.42	2.74	6.84	2.54	6.64	0.98	0.59	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	49.80	3.80	6.12	1.69	6.12	1.06	0.63	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	42.39	4.95	3.46	2.31	3.46	1.32	0.66	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	40.20	5.98	6.92	2.62	4.49	1.68	0.19	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	39.86	3.83	6.32	2.11	6.13	1.72	0.19	0.96	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.83	5.11	3.68	2.04	3.47	1.84	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.83	3.22	4.03	2.42	2.82	0.81	0.40	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	39.16	4.05	6.75	2.43	5.40	2.70	1.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	29.77	2.64	3.84	2.16	5.52	1.20	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	29.41	2.82	3.76	3.06	3.29	1.18	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.01	5.42	2.49	1.61	1.02	2.20	0.15	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	24.67	3.59	4.64	3.16	3.37	1.48	0.84	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	33.74	3.15	3.32	2.62	5.07	1.40	0.00	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.09	2.81	5.22	3.81	3.01	1.20	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.33	1.86	5.35	4.19	2.09	1.40	0.23	0.23	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.55	2.40	4.08	0.96	2.16	1.20	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.48	1.49	3.58	2.38	1.19	0.89	0.89	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.40	2.39	2.87	2.63	2.39	1.44	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.15	3.03	2.02	1.62	1.42	1.01	0.20	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.99	2.46	3.69	2.05	1.84	1.43	0.20	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.68	1.56	2.45	3.78	1.33	0.67	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.61	3.90	2.84	3.19	0.71	0.71	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.21	3.31	1.33	2.65	1.33	0.99	0.33	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.87	9.23	0.00	0.00	0.84	2.52	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.75	5.05	0.00	0.92	0.00	0.92	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.15	1.94	5.19	1.30	2.27	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.95	1.28	3.21	3.21	0.96	0.32	0.64	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.12	5.03	1.26	1.26	0.63	1.89	0.31	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	1.41	4.94	4.94	0.00	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.14	2.24	2.80	2.80	1.12	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	11.94	0.80	0.80	0.80	1.59	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.71	4.42	1.70	3.06	0.34	0.34	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.04	0.65	4.55	7.15	2.27	0.00	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.46	1.06	5.68	5.32	1.06	1.06	1.42	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	55.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	0.49	0.49	2.93	1.95	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.89	0.99	0.99	0.99	2.48	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	2.35	3.28	3.28	0.47	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.27	2.98	2.65	2.32	0.33	0.00	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.14	0.31	4.33	1.24	0.62	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	0.31	3.97	1.83	1.83	0.31	0.61	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	10.93	2.06	2.69	2.53	0.79	0.95	0.16	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	7.86	2.57	5.45	0.64	0.96	0.96	0.80	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	10.05	2.29	2.04	2.16	1.65	0.89	0.25	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	8.97	2.99	3.74	1.49	1.49	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	9.04	2.01	2.01	1.67	2.01	0.33	1.00	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	9.57	0.00	3.19	0.00	0.00	0.64	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	1.10	1.10	1.10	0.00	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.16	0.90	3.16	2.26	0.00	0.90	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	6.78	2.61	4.17	1.22	1.91	0.70	0.87	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	23.08	4.69	8.61	9.00	5.48	1.56	0.98	1.56	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	12.61	2.57	3.09	2.06	2.83	1.80	2.57	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	23.70	5.02	6.69	3.90	3.07	0.84	1.67	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	12.34	6.47	4.70	0.59	0.59	1.18	2.35	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	13.91	4.42	6.92	2.25	3.70	1.13	0.64	0.08	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	18.40	2.26	6.13	2.58	1.29	0.32	1.61	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	4.27	2.67	1.60	2.67	0.53	0.53	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	9.46	1.67	3.34	1.67	0.56	0.56	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	6.65	3.33	4.57	0.83	1.66	0.42	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	8.54	0.75	2.01	2.01	3.27	0.50	0.25	0.25	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	8.51	2.62	3.60	0.65	1.96	0.33	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	2.44	2.13	0.00	0.91	0.30	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.72	10.61	3.31	1.99	2.43	0.88	0.88	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	12.91	7.53	7.17	2.15	1.43	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	3.59	5.99	2.40	1.20	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.48	5.94	3.42	1.08	1.98	0.90	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	5.02	6.69	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.51	6.57	6.99	2.05	2.05	1.64	0.00	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.81	8.12	1.60	1.72	0.57	1.49	0.46	0.23	0.57
Anulus Pulposus Cell, donor2	11463-119B5	8.57	4.90	1.71	2.20	0.49	1.71	0.98	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.78	5.84	0.90	3.59	1.35	0.90	0.45	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.72	3.47	0.87	2.60	2.60	1.30	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	2.14	2.14	6.42	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.55	4.18	2.39	3.89	1.20	1.20	0.00	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	5.06	6.32	3.79	0.00	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	1.98	1.32	4.62	0.00	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	2.92	1.95	3.25	0.65	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.77	5.34	2.91	1.94	1.46	0.49	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.10	3.56	2.38	4.75	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.16	4.90	0.75	3.77	0.75	1.51	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.14	4.35	1.45	4.35	0.00	3.63	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	2.51	3.76	3.76	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.83	4.61	2.47	3.29	0.49	1.98	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	2.73	0.00	4.09	1.36	2.73	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.95	1.81	1.66	2.87	1.36	0.75	0.15	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	7.50	1.07	2.14	3.21	0.54	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.26	3.40	3.40	2.65	1.32	2.27	0.19	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.36	5.61	1.87	4.54	1.07	1.34	0.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	1.95	2.93	1.95	1.95	2.93	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.96	4.81	4.48	5.31	1.16	1.82	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	2.40	2.40	6.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	3.54	3.54	0.00	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	11.49	5.15	5.15	3.43	0.69	1.89	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	3.40	0.00	4.37	1.94	2.43	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.07	4.55	4.17	3.04	1.90	3.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	1.21	3.63	1.21	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	5.13	2.85	2.85	1.71	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.12	6.63	4.28	5.13	3.85	0.86	0.00	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.68	1.81	2.58	4.13	0.52	0.77	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	6.10	2.35	5.16	1.41	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.90	3.86	3.22	3.22	1.61	1.29	0.32	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	5.71	2.14	2.14	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	5.26	0.00	0.58	1.17	1.75	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.14	3.31	5.42	4.22	1.51	1.51	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	3.56	1.19	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.22	5.59	3.05	3.56	2.54	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	4.84	4.58	4.84	2.80	2.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.35	1.27	2.54	2.54	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	6.04	1.73	3.45	1.73	0.86	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.20	4.23	4.45	3.39	1.48	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.60	2.32	2.61	3.19	0.00	0.58	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	6.61	0.94	3.78	0.94	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.65	2.88	5.09	4.75	0.68	1.70	0.00	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	6.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	4.23	4.23	4.23	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.86	3.65	1.93	2.79	1.07	0.64	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	3.61	1.20	3.61	1.20	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	5.83	0.00	2.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	4.37	2.53	2.30	1.15	2.07	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.64	1.53	1.78	3.05	0.76	0.51	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.91	4.13	3.72	3.72	1.03	2.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	3.98	3.67	3.37	1.53	1.84	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.04	5.74	1.91	1.91	0.96	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.09	4.21	3.77	4.43	2.66	0.89	0.67	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	4.58	6.10	3.05	1.53	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	4.43	2.22	3.32	2.22	1.66	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	5.30	3.44	3.44	1.59	0.53	0.00	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.18	2.91	1.09	4.00	0.36	1.82	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	28.00	11.42	5.04	3.19	2.33	2.95	1.35	0.49	0.25
Astrocyte - cerebellum, donor2	11580-120F5	19.34	6.50	6.50	2.91	2.57	1.03	1.37	0.17	1.54
Astrocyte - cerebellum, donor3	11661-122F5	22.23	8.18	4.61	2.52	1.68	0.63	0.63	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	12.55	11.50	4.53	0.70	1.74	2.09	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	10.52	10.68	9.38	0.32	2.91	2.91	0.32	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	9.55	7.16	6.41	1.34	2.83	3.28	0.15	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.02	9.17	12.39	8.49	2.87	1.95	0.57	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.29	7.77	10.77	5.89	1.63	2.63	0.63	0.13	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.34	8.31	9.33	5.92	3.07	2.39	0.80	0.11	0.23
Basophils, donor1	12241-129G9	13.08	3.66	4.71	21.45	0.26	0.52	0.52	0.26	0.00
Basophils, donor2	12242-129H1	35.72	4.69	7.22	20.93	1.08	1.44	0.36	0.00	0.36
Basophils, donor3	12243-129H2	20.87	2.79	7.35	36.01	1.62	0.73	0.00	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	6.90	17.68	6.90	1.29	1.94	2.37	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	17.83	3.20	0.46	5.94	1.37	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	16.32	5.02	0.63	1.88	1.88	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	9.15	13.72	5.20	3.33	2.29	1.25	0.21	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	5.53	7.83	1.84	0.92	1.38	1.38	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	5.40	12.42	4.14	0.54	1.80	0.90	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.36	0.41	9.48	11.23	3.61	0.10	0.21	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	20.03	2.56	12.11	8.85	3.96	0.23	0.23	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	16.31	6.72	3.84	14.39	2.24	3.84	0.64	1.60	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	31.03	20.68	10.34	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	22.54	2.25	5.64	24.80	2.82	0.56	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	22.83	2.60	14.29	26.17	2.60	1.11	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	27.66	3.95	14.05	29.64	2.20	1.10	0.66	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	30.57	0.57	8.77	20.10	4.25	0.28	0.28	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	27.29	0.00	9.10	13.27	5.69	0.38	0.00	0.00	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	1.64	13.81	20.71	5.26	0.00	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	27.18	4.34	10.12	22.41	0.72	1.73	0.00	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	25.95	3.32	4.22	18.10	0.60	1.21	0.60	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	32.22	4.26	7.34	28.43	1.18	2.13	0.95	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.38	1.84	2.34	10.38	1.00	0.84	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.14	0.55	2.48	8.83	0.55	1.10	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	13.64	1.74	2.73	13.14	0.74	0.50	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.29	0.98	2.35	9.20	0.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.40	1.60	2.49	8.90	0.53	0.18	0.18	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	13.49	1.96	2.61	11.75	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.54	1.40	2.81	13.81	0.70	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.35	0.53	2.11	15.84	1.58	1.06	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	3.33	9.98	14.42	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.81	2.68	4.16	18.30	0.15	0.89	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.56	2.20	1.60	14.37	0.20	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	15.20	2.08	1.67	16.24	0.00	1.67	0.00	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.35	0.92	2.52	12.81	0.23	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.06	1.58	1.13	8.14	0.45	0.90	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.40	3.49	2.62	10.91	0.44	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.60	3.77	1.08	17.22	0.00	1.88	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	21.28	2.09	2.44	20.24	1.05	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.88	5.05	1.68	17.67	0.42	0.84	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.43	0.73	2.57	6.06	0.18	0.18	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.52	1.76	0.35	3.87	0.70	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	0.44	0.00	3.95	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.33	2.27	3.66	8.20	0.52	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	0.74	3.72	10.04	0.00	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.32	2.16	1.72	10.35	0.43	0.43	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	1.64	4.09	9.01	0.82	0.00	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.03	0.70	0.23	4.87	0.46	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.26	1.16	1.39	6.03	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	18.74	1.53	4.58	19.40	0.65	0.65	0.87	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	16.40	2.54	9.01	24.02	0.69	0.69	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	10.40	0.65	4.55	10.61	1.08	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	23.36	1.56	7.63	22.74	2.65	1.40	0.47	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	15.02	1.92	5.76	19.56	0.87	0.17	0.00	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	22.07	1.78	11.15	19.62	2.01	1.11	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	29.35	1.02	3.06	23.22	1.53	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	32.72	1.32	7.47	27.45	1.32	1.32	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	28.42	0.84	7.79	19.58	1.68	0.63	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	0.00	6.10	28.45	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	34.58	1.36	5.42	25.09	2.03	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	31.07	1.04	7.25	30.03	3.11	1.04	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	33.05	1.07	5.86	20.79	2.13	0.00	2.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	36.45	2.14	7.50	46.10	0.54	1.07	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.06	0.00	5.62	27.38	0.00	1.40	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	0.78	8.63	34.51	3.14	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	2.64	5.27	31.64	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	55.89	0.82	7.40	69.86	4.93	1.64	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	48.60	0.00	4.35	42.07	3.63	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	46.44	1.51	7.57	46.95	3.03	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	11.72	117.98	6.87	1.62	3.23	20.61	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.59	67.51	3.99	0.40	3.99	14.38	0.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	24.10	15.06	8.03	18.07	1.00	2.01	2.01	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	16.85	12.92	3.37	23.03	0.00	1.69	0.56	2.81	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.42	41.71	9.77	12.40	7.14	9.77	0.38	1.50	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	19.17	48.70	6.54	11.73	3.38	7.89	0.90	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	69.98	10.00	10.35	90.34	3.57	2.14	1.43	3.21	1.79
CD4+ T Cells, donor2	11306-117C1	56.95	5.51	7.96	74.71	3.06	1.84	3.06	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	48.80	4.27	15.25	55.51	3.35	3.35	2.13	3.05	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	35.73	16.34	6.89	61.51	2.55	3.57	2.04	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	45.14	11.01	8.09	75.91	4.94	2.47	1.57	1.12	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	51.74	11.21	14.09	85.66	3.45	4.02	0.86	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	48.36	4.74	4.74	61.16	1.90	1.90	2.37	3.32	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	42.84	5.62	8.43	59.70	2.81	0.00	2.11	3.51	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	6.59	9.89	46.15	9.89	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.89	12.14	9.10	54.48	2.02	2.75	0.87	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	36.10	11.02	14.57	52.19	2.20	3.56	0.85	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.75	9.51	10.16	53.36	2.58	2.42	0.32	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	20.62	4.03	6.72	45.73	3.59	0.90	0.00	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	26.90	4.19	5.59	40.53	3.14	1.05	0.35	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.36	5.28	9.68	48.40	1.32	2.64	0.00	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	35.84	9.28	4.22	55.66	0.42	4.22	2.53	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.92	8.10	8.10	54.02	1.87	1.25	0.83	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	34.08	6.01	9.69	41.43	0.67	3.01	0.67	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	66.90	7.34	8.70	82.40	3.26	2.99	4.08	6.25	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	55.20	8.04	8.58	76.64	1.61	1.61	3.75	3.75	4.29
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	68.14	14.35	8.97	75.32	3.59	0.00	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	27.07	11.31	7.05	53.03	1.48	4.26	2.04	0.19	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.26	9.10	6.07	49.61	3.03	4.33	0.65	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	30.26	7.99	10.09	58.21	2.52	2.94	0.42	0.21	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	28.31	5.56	4.55	46.52	1.52	3.54	3.54	3.03	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.93	6.50	7.80	45.06	2.17	1.30	0.43	1.73	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	44.89	6.54	10.90	50.12	3.05	1.31	1.74	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	40.08	10.89	14.85	52.46	0.99	3.46	1.48	1.48	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	22.16	4.62	9.23	47.08	0.92	0.92	0.92	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	26.52	2.79	2.79	46.06	5.58	0.00	0.00	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	44.31	8.86	7.75	42.37	3.60	0.83	2.49	1.38	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	41.47	10.06	7.12	53.50	2.94	1.47	2.70	2.70	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	50.82	6.16	7.70	58.52	1.54	1.54	3.08	3.08	9.24
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	42.97	5.37	12.53	56.58	5.01	3.94	2.86	1.79	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	34.62	4.15	13.85	37.39	2.77	2.77	0.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	60.24	8.18	10.15	58.60	2.95	1.31	1.64	1.96	0.00
CD8+ T Cells, donor2	11307-117C2	64.57	4.13	8.63	47.30	3.00	2.63	1.13	2.25	0.38
CD8+ T Cells, donor3	11383-118B6	68.42	10.10	10.35	73.47	2.78	2.52	1.77	7.32	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.44	2.29	1.84	2.75	0.46	0.92	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.31	1.92	0.48	4.07	0.48	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.38	2.74	0.82	3.56	1.09	0.55	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	1.80	1.50	1.20	0.60	0.30	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.32	2.40	1.44	1.92	0.72	0.72	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.46	2.05	0.91	3.18	0.91	1.59	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.61	0.87	1.09	3.26	1.52	0.87	0.00	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.95	1.58	1.32	3.42	0.79	0.79	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.35	1.41	2.35	2.58	0.47	2.11	0.47	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.11	0.60	1.81	6.04	1.51	0.91	0.91	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	1.16	2.03	5.23	1.16	1.16	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	3.73	0.80	1.07	1.33	0.53	0.53	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.06	2.19	3.06	2.19	1.31	2.19	0.88	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.01	1.37	1.82	1.37	1.37	2.28	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	0.75	3.73	2.24	0.75	0.75	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.32	3.24	1.80	2.16	0.72	1.80	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.88	0.58	2.30	3.45	1.15	0.58	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.83	2.83	1.41	3.77	0.71	0.47	0.71	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.12	4.12	1.58	3.80	1.58	0.95	0.63	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.69	1.23	1.85	2.77	0.62	0.31	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.21	0.64	1.60	4.17	1.28	1.60	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.68	1.53	1.15	2.29	0.38	1.15	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	2.76	1.58	1.18	2.36	1.18	0.39	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	0.00	0.76	1.51	1.51	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	12.04	4.01	2.41	1.61	3.21	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	7.69	5.60	0.70	5.60	1.40	2.80	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	8.01	4.01	0.00	2.00	3.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	14.62	20.11	14.62	1.83	5.48	0.00	1.83	0.00	5.48
Cardiac Myocyte, donor2	11605-120I3	6.92	7.41	1.98	3.95	2.47	0.99	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	5.89	2.10	4.63	2.10	2.21	0.21	0.32	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	12.13	2.08	2.08	1.04	0.69	0.35	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	14.93	4.26	3.20	2.84	0.71	0.71	2.13	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.52	2.73	5.58	1.37	2.16	1.02	0.46	0.80	0.11
Chondrocyte - re diff, donor2	11339-117F7	25.96	8.95	8.95	7.16	2.69	0.90	1.79	4.48	1.79
Chondrocyte - re diff, donor3	11411-118E7	14.15	2.83	9.71	5.26	1.21	0.00	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	25.02	13.89	7.92	3.67	2.98	3.21	0.92	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	20.95	8.55	7.05	2.78	2.35	2.57	0.43	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	20.89	10.71	9.47	4.96	3.19	2.12	0.27	0.27	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.29	6.33	11.55	8.34	6.69	1.93	2.75	1.38	1.74
Corneal Epithelial Cells, donor1	11526-119I5	9.22	21.96	5.49	1.76	1.98	2.20	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	23.89	4.55	0.00	2.28	5.69	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.16	18.66	5.11	1.53	2.30	2.81	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.42	1.32	4.62	12.38	1.32	0.33	0.50	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.18	0.32	5.68	9.46	1.58	0.00	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	0.00	10.35	3.45	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	20.63	1.40	7.99	13.39	3.24	0.32	0.11	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.69	4.78	2.05	9.57	1.02	1.37	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.06	3.92	2.61	7.83	0.65	0.65	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	3.39	2.42	5.81	1.45	0.97	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	5.34	9.17	2.00	16.34	0.50	2.00	0.17	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	2.35	6.45	1.17	9.39	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	2.55	13.86	3.11	16.12	1.70	1.98	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	4.33	11.40	1.97	18.48	0.39	1.97	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	2.91	5.53	1.16	14.25	1.45	2.04	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.00	5.65	2.12	15.29	0.94	2.12	0.24	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	3.86	7.54	1.93	18.06	0.70	1.58	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	3.10	5.98	3.10	12.41	1.11	1.77	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	4.87	7.61	3.04	20.08	0.61	0.91	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	4.79	5.07	2.82	18.89	1.41	1.41	0.28	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	7.13	0.89	19.61	1.19	0.30	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	2.60	3.64	1.04	12.50	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	3.83	9.64	2.41	18.86	1.42	1.42	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	8.40	5.60	3.20	18.41	0.40	0.80	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	12.05	3.14	9.43	1.57	1.05	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	5.09	7.33	2.98	20.38	0.87	1.62	0.12	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	5.21	8.69	4.56	16.73	0.43	1.30	0.22	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	3.18	8.67	3.54	21.62	1.22	0.85	0.12	0.00	0.24
Endothelial Cells - Vein, donor1	11267-116G7	2.28	12.51	3.41	14.79	1.14	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	13.27	1.40	14.67	1.40	2.79	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	4.08	13.50	4.71	12.40	0.79	1.57	0.31	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	47.86	14.85	11.55	51.16	0.00	6.60	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	49.94	3.57	24.97	35.67	7.13	3.57	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.82	20.52	4.40	0.98	0.98	2.69	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	6.24	0.00	2.08	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.42	4.11	6.98	2.05	1.23	0.00	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.32	0.99	0.99	1.97	0.77	0.33	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.62	1.41	1.95	1.95	0.98	0.43	0.87	0.11	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	11.89	6.67	3.52	4.00	0.85	1.33	0.49	0.12	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	48.99	12.28	14.60	4.78	5.32	7.37	0.82	0.14	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.77	4.01	4.54	1.69	2.43	1.58	0.32	0.63	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.87	9.49	4.74	2.37	3.43	1.05	2.11	0.79	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.95	7.31	5.32	4.65	1.99	1.00	1.00	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	11.79	5.90	2.27	1.36	1.36	3.18	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	9.85	4.55	0.76	3.03	0.00	1.52	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.14	4.42	6.31	5.52	2.52	3.15	0.16	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	16.67	4.85	8.18	4.24	3.03	1.21	0.61	1.21	0.91
Fibroblast - Cardiac, donor5	11456-119A7	6.22	3.43	3.43	5.84	1.14	1.14	0.25	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	4.85	2.58	2.73	5.31	1.67	0.45	0.30	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.70	5.63	6.97	3.35	3.35	1.74	1.88	0.94	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	23.73	5.61	7.33	4.75	2.59	1.29	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	1.46	8.79	5.86	4.39	5.86	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	10.15	4.15	3.23	1.61	1.61	0.46	0.69	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	14.59	7.97	3.39	3.22	2.37	4.92	1.02	2.88	0.34
Fibroblast - Dermal, donor1	11269-116G9	7.04	4.23	3.76	1.64	0.70	1.17	0.23	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	5.66	6.13	2.83	2.83	1.42	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.77	3.75	3.99	2.54	0.85	0.73	0.36	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	2.83	4.63	4.63	1.02	0.68	1.36	0.23	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	4.88	3.84	3.49	2.27	1.22	0.52	1.05	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	4.39	2.92	4.55	1.14	1.46	0.81	0.49	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	7.70	4.16	4.37	2.50	0.62	0.83	0.42	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.06	5.24	6.55	3.41	2.10	1.05	2.10	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	8.83	6.98	7.25	2.11	1.58	1.58	0.26	0.13	0.79
Fibroblast - Gingival, donor3	11394-118C8	8.03	4.83	5.61	0.97	1.35	0.68	0.19	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	8.31	5.19	1.04	1.04	1.04	2.08	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.98	5.11	4.76	0.88	1.59	1.59	1.06	1.76	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.03	7.48	6.70	3.59	1.71	0.62	1.25	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.58	5.00	3.79	1.35	0.27	1.35	1.08	1.35	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.35	8.12	3.53	1.41	2.12	3.53	0.35	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.65	2.78	2.19	1.90	1.17	1.02	1.17	1.02	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.27	4.50	4.23	2.73	0.82	1.09	0.82	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.45	3.62	2.30	1.21	0.66	0.99	1.10	0.88	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.37	9.24	4.11	1.17	1.61	2.93	3.37	4.26	1.32
Fibroblast - Lung, donor1	11270-116H1	2.72	4.08	1.36	1.36	5.44	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	1.49	10.45	2.98	4.48	0.00	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	6.75	6.54	5.91	2.11	1.48	2.74	0.84	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	4.17	5.00	5.00	5.00	1.67	0.00	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	4.20	1.40	1.40	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.20	3.36	1.68	2.80	1.96	0.56	0.28	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	11.37	6.90	6.09	4.87	0.81	2.03	0.00	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	3.99	0.00	0.00	0.00	3.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	5.63	7.76	4.85	1.55	0.78	1.94	0.58	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	6.67	8.49	7.74	2.58	2.73	1.82	1.21	0.15	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	5.20	4.90	2.75	2.14	0.61	1.84	0.61	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.78	3.82	3.82	0.00	0.76	0.38	1.53	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	2.97	1.62	1.62	1.08	0.81	1.08	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.97	3.48	5.22	1.97	1.51	1.16	0.93	1.74	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.75	3.32	3.98	2.65	0.88	1.66	0.66	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.55	6.91	6.71	4.27	1.22	0.41	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.01	7.35	6.68	4.68	0.67	0.00	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.72	1.58	3.95	3.95	1.58	0.79	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.21	12.90	5.36	1.98	3.18	1.59	1.39	1.19	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.99	3.20	6.57	1.78	3.55	2.31	1.60	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.01	3.55	3.94	1.77	1.77	1.58	0.39	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.75	6.32	6.62	2.11	3.91	0.90	0.60	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.33	4.32	3.35	1.84	1.94	0.43	1.73	0.54	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.09	10.38	8.10	1.27	6.33	2.28	1.52	1.01	0.25
Fibroblast - skin normal, donor1	11553-120C5	13.95	4.76	3.77	1.15	1.80	1.48	0.16	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	19.25	13.23	7.62	2.41	3.41	4.41	0.40	0.20	1.20
Fibroblast - skin normal, donor2	11561-120D4	20.39	6.03	5.53	2.61	2.91	1.00	1.31	0.40	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	34.46	6.95	11.79	2.12	4.84	1.51	1.81	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.11	4.39	5.63	2.15	2.65	1.91	1.49	1.24	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	23.93	4.10	3.25	1.71	3.08	1.54	1.88	2.05	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	31.53	10.84	9.85	4.93	2.96	0.99	4.27	2.63	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.64	6.28	3.73	2.34	2.13	1.38	1.81	0.85	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	12.65	7.76	5.57	1.86	1.86	0.34	1.18	0.67	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.31	2.82	0.94	0.78	0.16	0.78	0.78	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.09	18.30	13.07	2.61	0.00	3.49	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.15	12.48	4.33	2.60	0.69	3.29	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	6.25	12.23	6.77	2.60	2.86	4.42	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.48	17.12	5.88	1.79	2.04	1.53	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	6.12	5.36	0.00	0.77	1.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	11.49	8.29	1.28	1.28	2.55	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.28	7.99	11.70	0.29	2.57	2.57	0.86	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	18.75	26.20	14.34	1.10	8.00	9.10	0.28	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	25.34	13.47	10.27	19.18	5.25	8.22	0.68	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.71	9.31	12.88	0.79	3.96	1.78	0.20	0.40	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.27	21.94	11.63	1.85	5.55	7.14	0.00	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	24.46	21.53	10.76	4.57	5.22	7.50	0.33	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.10	11.06	9.29	0.44	1.33	0.88	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	7.77	13.14	15.55	0.85	3.11	3.82	0.00	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.33	15.76	11.58	1.11	4.68	5.05	0.12	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.60	10.21	11.55	0.54	6.18	3.49	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	8.55	13.38	9.04	1.86	4.09	3.10	0.12	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.37	10.94	8.17	0.55	4.15	2.77	0.14	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	4.47	9.96	6.30	0.41	2.85	3.25	0.20	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.38	14.83	12.78	3.19	5.25	3.42	0.68	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	7.72	17.31	10.59	1.49	3.61	3.49	0.37	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	5.68	13.11	11.80	1.09	4.15	3.93	0.00	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.39	12.11	9.75	2.95	7.98	2.95	0.89	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.74	17.64	11.13	1.27	3.02	4.77	0.00	0.32	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	12.29	8.49	15.42	1.79	8.27	4.24	0.22	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.57	14.52	12.50	2.42	7.26	4.23	0.60	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.08	16.96	7.12	1.53	3.56	6.79	0.00	1.02	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.42	12.15	11.44	3.37	4.34	4.79	0.44	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.14	7.18	15.19	6.14	14.98	5.62	0.42	1.04	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.23	8.03	15.20	7.00	12.13	4.61	1.02	1.02	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.12	12.61	12.50	4.09	6.53	3.43	0.33	0.44	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.55	9.48	9.40	2.91	6.82	6.16	0.75	0.92	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.56	16.54	8.58	2.45	4.29	3.27	0.82	0.82	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	23.73	11.35	14.24	5.98	8.66	3.51	0.83	0.00	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.29	10.26	15.45	4.27	9.34	3.69	0.81	1.84	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.85	10.67	11.84	4.50	9.34	4.84	1.00	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.29	9.48	16.31	4.63	11.24	4.19	1.98	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.30	13.41	17.71	4.67	11.68	4.06	1.11	1.48	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.75	12.97	11.35	2.76	8.27	5.84	0.32	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.32	8.98	10.90	5.77	14.75	2.89	0.96	0.96	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.73	10.23	11.37	3.98	6.25	5.02	0.76	0.76	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.57	7.91	13.92	6.17	8.23	2.53	1.27	0.95	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	31.63	11.25	13.68	5.47	6.69	4.56	0.61	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	25.09	13.28	12.86	4.70	7.32	5.54	1.25	1.15	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	24.37	7.90	9.88	5.93	6.59	3.29	0.88	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	31.42	8.98	9.82	4.49	7.29	2.24	0.28	0.28	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.44	12.59	9.44	4.63	4.26	4.35	0.56	0.56	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.19	8.02	8.56	5.88	6.95	2.94	0.80	0.53	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.20	7.50	11.48	4.28	4.74	3.06	0.31	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.98	10.23	7.51	5.18	3.11	3.24	0.65	0.39	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.02	7.32	12.20	4.34	7.86	2.17	0.54	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	36.69	11.06	14.38	6.45	9.59	4.24	0.92	1.29	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.90	13.60	14.04	5.70	7.68	5.70	1.75	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	63.47	16.86	31.74	14.88	19.83	1.98	2.98	1.98	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.02	9.89	9.23	4.62	6.07	5.54	1.19	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.25	10.69	10.29	3.83	4.84	4.64	1.61	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	84.89	14.49	31.01	17.79	19.82	11.95	3.56	4.57	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	4.58	15.73	12.14	0.00	3.58	2.39	1.00	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.85	18.64	20.95	0.00	6.78	1.85	0.31	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	3.48	21.69	15.96	0.41	5.52	3.89	0.20	1.02	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.01	6.57	4.38	1.56	2.50	1.56	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.22	3.39	5.09	1.13	1.13	1.70	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.46	6.00	6.00	0.00	0.92	2.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	14.85	0.00	0.00	7.42	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	6.58	10.83	9.67	0.77	1.93	3.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	11.23	8.02	3.21	0.00	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	8.69	10.43	0.00	1.74	3.48	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.86	6.51	5.86	0.33	3.91	2.93	0.33	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.35	9.06	8.24	0.41	2.47	2.88	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	10.00	6.66	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	11.19	10.07	6.71	1.12	2.80	2.80	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.82	10.46	8.17	0.98	2.94	3.60	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.07	9.23	15.10	2.52	5.87	5.87	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.45	10.81	6.36	0.32	3.50	2.23	0.00	0.95	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.45	9.17	7.13	0.00	5.09	1.02	0.00	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	6.26	10.44	0.00	8.35	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.03	8.59	6.30	0.57	5.15	4.58	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.88	7.10	7.99	0.59	2.96	3.55	0.30	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	8.47	5.08	1.69	1.69	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.85	10.36	9.53	1.24	4.97	4.97	0.00	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.11	14.73	10.59	2.30	5.52	4.60	0.69	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	15.81	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.22	6.15	4.23	1.15	5.00	2.31	0.77	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.06	4.24	10.43	1.63	3.59	2.28	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	9.36	4.01	8.69	0.67	1.34	1.34	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.94	7.71	10.40	0.39	5.01	1.93	0.39	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	24.31	9.59	7.19	2.05	5.82	5.82	0.00	2.40	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	17.39	9.94	0.00	12.42	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.99	7.55	13.68	0.00	8.02	1.42	0.00	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	8.45	11.47	4.83	0.00	6.03	3.02	0.60	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	7.12	3.56	0.51	6.10	2.03	0.51	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.95	7.98	9.97	2.39	7.18	1.99	0.80	0.40	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	8.39	9.87	0.99	6.41	0.49	1.48	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	8.26	4.72	8.26	0.00	3.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	9.34	10.50	0.00	5.25	1.75	0.00	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	11.41	8.34	8.78	2.19	7.02	0.44	0.00	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	3.39	9.32	0.00	5.09	2.54	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.71	3.58	6.57	2.98	3.58	3.58	0.60	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.44	7.28	3.88	0.97	2.43	0.97	0.00	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	3.42	3.42	4.57	2.28	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.09	3.33	7.48	2.91	1.66	1.66	0.83	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	9.00	15.74	4.50	3.37	2.25	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.66	4.12	8.56	3.81	2.85	3.17	1.90	1.90	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	2.51	2.92	1.67	1.25	0.84	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.27	2.32	3.48	0.46	1.51	1.16	0.23	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	5.74	1.69	4.39	0.51	1.52	1.18	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	3.87	3.19	3.87	0.00	1.14	0.68	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	6.34	2.30	2.30	0.11	0.87	1.09	0.11	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	4.73	4.30	4.08	0.43	0.86	1.07	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	5.38	3.23	2.15	1.29	0.86	0.00	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.49	3.36	1.74	0.37	1.25	1.12	0.37	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.12	1.89	3.26	0.17	0.51	0.34	0.17	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1.60	2.88	1.28	0.64	1.28	1.28	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	8.39	2.80	28.54	1.12	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	8.22	7.79	8.66	1.73	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	2.64	0.00	15.86	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.75	10.23	8.47	3.53	4.94	2.82	1.76	1.76	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	5.81	7.27	8.72	4.36	2.91	4.36	2.91	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.72	5.59	2.62	3.32	0.70	0.70	0.52	0.35	0.00
Hepatocyte, donor1	11523-119I2	7.26	0.00	2.42	0.00	2.42	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	11.85	1.08	5.39	0.00	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	6.75	0.00	1.84	4.29	0.61	0.61	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	19.58	16.97	7.18	21.54	2.61	5.22	6.53	6.53	5.22
Intestinal epithelial cells (polarized), donor1	11246-116E4	6.64	5.24	3.50	0.00	2.27	3.67	0.00	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	11.25	7.82	5.21	2.33	2.88	0.55	0.14	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	50.94	3.18	9.55	9.55	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	20.03	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	52.61	9.69	0.00	4.15	5.54	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	30.03	5.01	2.50	5.01	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	61.51	12.81	0.00	0.00	10.25	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	22.85	9.14	0.00	9.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	60.10	12.99	3.25	1.62	4.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	25.01	10.00	0.00	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	47.20	7.26	0.00	3.63	7.26	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	51.62	11.91	0.00	2.65	11.91	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	33.26	6.65	2.22	1.11	5.54	0.00	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	41.91	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.78	40.94	6.30	1.26	5.67	4.41	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	38.67	9.28	0.00	4.64	9.28	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.88	36.82	9.04	0.65	6.46	4.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	38.64	16.10	0.00	1.61	8.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	39.11	12.22	0.81	3.26	6.52	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	44.92	10.92	0.84	3.36	7.14	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	47.42	4.82	1.61	4.82	4.02	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	25.85	4.62	0.92	2.77	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	45.24	15.08	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	31.15	5.19	0.47	2.36	1.42	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	31.74	7.26	0.00	1.81	4.53	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2.15	29.06	9.69	0.00	3.23	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	36.84	15.25	1.27	5.08	5.08	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	38.90	3.83	1.91	3.19	5.74	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	36.45	3.65	0.00	1.82	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	9.28	39.27	14.28	0.00	0.71	5.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	56.41	0.00	0.00	9.95	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.01	38.89	6.48	0.31	1.85	7.41	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	66.73	19.32	1.76	7.02	10.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	62.86	6.29	0.00	6.29	12.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	62.58	4.87	0.70	0.70	4.17	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	48.69	6.64	2.21	0.00	8.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	38.90	6.48	3.24	9.73	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	34.01	6.98	0.00	1.74	1.74	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	51.75	9.00	4.50	2.25	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	20.91	10.45	0.00	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	45.87	11.73	2.13	3.20	5.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	33.25	2.77	1.39	5.54	4.16	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	34.20	8.55	2.85	5.70	8.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	34.06	10.12	0.00	4.60	4.60	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	36.30	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	37.25	12.42	6.21	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	41.24	2.11	1.06	2.11	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.83	14.04	4.57	1.22	1.96	4.24	0.00	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	2.93	16.40	1.17	0.00	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	8.42	12.40	6.44	1.14	2.27	2.37	0.19	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	9.19	26.11	7.15	1.70	1.70	3.41	0.11	0.00	0.00
Keratocytes, donor1	11527-119I6	11.35	8.94	7.91	1.38	2.41	1.38	0.34	1.03	0.34
Keratocytes, donor2	11607-120I5	3.52	5.86	4.69	2.34	0.00	0.00	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	8.50	5.53	6.92	2.96	1.98	0.99	0.20	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	24.18	2.20	0.00	2.20	6.59	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	7.55	14.02	4.31	3.24	3.24	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.68	16.72	10.73	1.73	7.73	5.42	0.46	0.12	0.35
Lens Epithelial Cells, donor3	11690-122I7	12.11	5.25	4.84	2.52	3.03	2.32	0.40	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	5.10	3.91	3.56	18.38	0.71	1.54	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.91	1.67	1.40	12.28	1.40	0.84	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.82	3.78	1.89	16.84	1.10	0.94	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	3.23	2.15	11.29	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.10	2.52	0.95	15.13	1.58	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.07	3.13	1.62	14.23	0.43	0.65	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.10	1.64	0.82	6.98	0.82	1.23	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	3.29	0.76	15.42	0.25	0.76	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.93	3.66	1.97	14.36	0.14	0.84	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	2.77	1.19	1.58	8.70	0.00	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.85	4.07	1.16	17.45	0.58	0.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.52	2.59	1.85	17.22	1.30	1.11	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4.88	3.14	1.39	10.10	0.70	0.70	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.01	2.86	2.39	16.94	1.67	0.72	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.04	3.02	1.79	14.42	1.10	0.14	0.27	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	3.70	2.46	2.46	15.40	1.54	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.87	1.25	1.56	14.34	0.62	0.31	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.59	2.74	1.10	18.85	0.91	0.91	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.62	1.65	1.65	14.81	0.33	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.27	2.34	1.46	17.28	0.59	0.29	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	2.49	1.24	16.43	1.00	0.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1.94	4.85	1.94	16.97	0.00	0.00	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.04	2.96	0.54	11.85	1.62	0.27	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.21	2.57	1.82	15.29	0.76	0.45	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	2.59	0.52	7.78	0.52	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.14	2.09	2.72	12.98	0.63	0.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.71	3.31	1.20	17.29	0.60	0.90	0.15	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	4.13	0.00	13.76	2.75	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	2.63	3.20	1.32	9.22	0.19	0.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.94	3.39	2.44	15.90	1.27	0.74	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	2.91	2.91	12.11	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.98	2.98	1.32	10.59	0.66	0.66	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.58	2.73	2.48	17.22	1.12	0.87	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.29	3.70	2.59	15.18	0.00	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.94	3.21	0.74	11.86	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.09	4.40	2.89	15.54	0.69	0.96	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	3.22	2.89	1.61	9.97	1.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.26	2.74	0.91	9.43	0.91	1.22	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.60	3.92	1.12	14.98	0.42	1.40	0.14	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1.78	3.20	2.13	9.96	0.71	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	3.39	2.91	10.18	1.94	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.98	3.73	2.96	19.61	0.62	0.93	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	3.94	1.79	10.74	0.00	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.96	3.27	1.63	11.76	0.33	1.31	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	3.53	1.41	13.65	0.00	0.71	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.32	5.07	3.22	17.08	1.11	1.86	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.10	3.33	1.28	11.27	0.51	1.02	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.56	5.97	1.79	14.02	0.30	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	2.27	11.33	0.00	0.00	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	10.74	6.14	2.30	4.60	3.84	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	6.68	5.94	1.48	1.48	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	44.01	10.16	3.81	2.12	2.96	4.65	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	10.55	10.55	1.41	3.52	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	38.29	5.60	3.74	0.00	2.80	2.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.34	4.12	3.09	0.52	1.55	2.58	0.00	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	7.14	8.33	0.00	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.01	7.69	5.43	0.90	2.26	3.85	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.92	5.53	3.78	0.87	0.87	2.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	21.16	4.05	6.30	0.90	1.35	3.60	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	38.07	9.75	7.72	2.17	3.25	4.06	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	26.19	4.62	6.16	3.08	1.54	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.64	4.23	4.23	1.76	1.41	3.18	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	20.66	5.33	4.66	0.67	2.00	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	28.53	6.11	4.08	1.53	1.53	3.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.55	7.20	7.20	1.33	1.87	1.33	0.27	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	28.34	6.05	3.78	1.32	3.21	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	37.43	5.52	6.14	0.61	2.45	3.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	33.43	6.52	5.71	1.63	0.82	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.53	8.75	5.00	1.25	3.75	2.50	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.54	3.92	3.08	0.84	1.40	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	22.67	12.36	6.18	1.03	4.12	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	21.19	5.23	6.10	1.45	3.77	1.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.11	7.17	4.78	0.90	2.99	1.49	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.58	3.87	1.66	1.66	0.55	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.52	6.36	8.13	2.12	3.18	2.12	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.76	3.69	3.69	2.21	1.48	2.58	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	2.30	8.06	3.45	1.15	5.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.78	7.68	3.07	1.92	3.45	1.92	0.77	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.34	3.96	8.49	1.13	1.13	2.83	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	6.56	2.46	0.82	3.28	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.37	7.68	6.33	1.36	1.36	4.97	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.85	7.18	1.44	0.72	2.15	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	7.47	2.24	0.00	8.22	2.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	30.47	7.06	4.09	2.23	2.60	2.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.09	3.02	3.88	0.86	2.15	1.29	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	6.85	5.14	1.71	1.71	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.66	7.66	7.66	1.00	2.33	1.67	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.69	3.02	4.83	1.21	2.41	2.41	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	4.27	3.55	0.71	2.84	2.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.97	6.53	5.50	1.03	4.47	1.72	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	5.90	4.83	2.68	4.29	3.76	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.20	2.69	5.39	0.00	2.69	4.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	7.04	6.30	2.22	1.11	1.48	0.37	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	10.47	2.33	0.00	1.16	4.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	20.10	6.35	5.29	2.12	8.46	1.06	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	21.61	5.60	7.60	2.40	3.20	5.60	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	41.43	7.27	6.54	2.18	6.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	9.96	6.90	2.30	6.13	4.60	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	36.50	5.43	5.92	0.99	3.95	2.47	0.00	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	30.11	5.65	1.88	2.82	2.82	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.17	6.03	8.55	2.01	4.53	4.02	0.50	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	8.56	5.86	1.80	5.86	1.80	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	32.70	10.33	1.72	1.72	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.72	10.24	8.91	2.23	3.56	3.56	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	32.85	3.91	10.95	1.96	2.74	1.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.31	7.26	4.62	0.00	3.30	1.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.06	7.78	10.38	1.56	3.63	1.04	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.32	7.88	4.38	1.75	3.50	2.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	5.03	2.24	2.24	0.56	2.24	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.73	6.18	8.39	0.44	4.86	3.97	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.07	10.41	7.33	1.54	3.09	1.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	31.90	5.57	5.06	1.52	1.52	3.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.55	7.21	8.17	0.00	2.88	2.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.01	5.96	6.76	1.59	2.39	3.98	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.95	4.25	2.43	1.82	0.61	1.82	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	4.15	2.77	2.08	2.08	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.12	4.56	5.70	1.90	2.28	3.80	0.38	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.34	5.16	4.65	0.00	4.65	4.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	5.44	1.81	1.21	3.02	2.42	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.35	3.80	6.34	3.49	2.85	2.54	0.95	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.65	5.33	4.80	1.07	1.60	2.13	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	3.45	2.30	1.15	2.87	0.57	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	35.48	5.14	7.20	3.09	1.54	3.60	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	7.07	5.66	1.41	2.12	2.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	3.40	5.11	0.57	2.27	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.87	6.24	9.15	2.91	2.08	1.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	22.71	7.05	2.35	0.00	1.57	4.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.54	2.51	0.84	0.42	2.09	0.84	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.51	5.11	4.18	0.93	3.72	2.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	21.41	6.69	2.68	1.34	2.01	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.18	4.28	3.21	0.53	1.07	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.57	4.85	2.02	1.21	2.42	0.81	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	4.59	3.67	0.92	1.84	2.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	2.67	1.78	0.89	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	22.22	8.55	7.41	2.28	0.00	1.71	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	7.67	6.14	2.30	4.60	2.30	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	24.62	3.28	2.19	0.55	3.83	1.09	0.55	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	28.06	10.25	9.80	1.34	3.56	4.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.00	6.24	3.64	0.52	3.38	4.16	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	3.98	1.33	1.99	1.99	0.66	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	4.16	6.24	2.08	6.24	10.39	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.90	0.68	5.01	15.73	2.73	0.00	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	11.38	0.55	4.04	5.14	1.47	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	16.39	1.57	7.08	10.75	2.88	0.26	0.13	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	4.78	1.06	0.00	1.59	4.25	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.24	11.41	3.80	0.79	0.79	3.17	0.00	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	5.56	9.87	3.06	1.25	0.56	2.22	0.00	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	3.99	10.06	1.79	1.20	0.30	1.49	0.10	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	2.90	13.61	1.74	0.58	0.58	2.90	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.23	13.72	2.49	0.50	0.75	0.75	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	10.17	0.00	0.68	18.98	0.00	0.68	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	25.95	2.70	7.46	42.39	4.00	0.97	0.76	0.11	0.43
Mast cell, donor2	11565-120D8	59.43	6.24	16.94	44.87	10.70	2.67	0.59	0.30	0.30
Mast cell, donor3	11566-120D9	42.77	6.98	20.26	49.98	11.71	2.25	0.90	0.68	0.23
Mast cell, donor4	11567-120E1	52.48	3.90	15.78	47.34	13.47	0.89	1.06	0.71	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	22.62	2.11	5.32	23.40	3.33	0.89	0.55	0.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	30.94	2.33	4.67	28.60	0.58	1.17	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	25.70	2.06	6.31	40.73	1.72	0.46	0.46	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	50.04	4.02	6.69	108.45	3.35	1.34	0.67	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	5.87	3.58	3.88	25.37	1.09	0.60	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	9.69	5.54	2.77	3.46	1.04	2.77	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	27.31	4.56	12.97	5.07	6.95	1.30	0.43	0.00	0.29
Melanocyte - light, donor1	11274-116H5	17.87	4.47	7.29	4.00	3.53	0.94	0.47	0.00	0.24
Melanocyte - light, donor2	11351-117H1	32.08	6.14	4.78	8.87	4.09	2.73	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	1.73	6.94	2.60	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.66	3.23	8.33	2.60	6.04	0.83	0.31	0.00	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	11.83	8.07	2.69	2.42	2.96	1.08	0.54	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	30.00	12.86	9.11	8.84	5.62	3.48	0.54	0.54	0.54
Meningeal Cells, donor1	11493-119E8	17.99	7.57	6.45	8.06	3.47	1.74	2.23	1.36	1.36
Meningeal Cells, donor2	11573-120E7	19.37	4.40	5.72	2.64	3.08	0.44	0.88	0.88	1.76
Meningeal Cells, donor3	11654-122E7	13.77	5.13	5.62	5.79	1.55	1.55	0.57	0.49	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.13	7.98	4.28	2.00	0.29	1.71	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	20.83	3.82	3.12	4.03	2.01	2.21	0.20	0.20	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	2.63	5.26	3.94	1.31	0.00	0.00	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	6.54	2.62	2.62	1.31	0.00	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	2.87	0.72	2.15	2.15	0.00	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.92	5.72	6.35	2.54	1.06	1.69	0.85	0.21	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	4.52	2.51	2.01	1.01	1.01	1.51	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	11.87	3.30	2.20	0.88	2.42	0.88	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	7.31	2.92	6.58	0.00	0.73	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.37	8.80	4.50	3.07	0.82	0.41	0.61	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.45	9.14	1.94	1.94	0.55	1.80	1.52	1.25	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	19.70	1.49	6.32	3.72	3.72	1.49	1.49	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	19.60	2.63	5.39	3.42	3.29	0.92	0.92	1.18	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.80	7.42	7.42	6.23	3.56	3.26	0.89	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	4.67	2.34	2.34	0.00	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	12.17	3.20	2.56	2.56	0.64	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	2.84	1.77	3.90	2.84	0.35	1.06	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.69	3.44	5.94	4.07	3.13	0.63	0.63	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	5.08	3.63	1.45	3.63	0.00	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	24.40	8.22	5.57	1.86	1.33	1.86	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	14.01	13.01	6.51	2.00	1.50	1.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	15.61	4.91	6.58	3.18	3.61	1.23	0.14	0.29	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	5.40	1.35	12.15	1.35	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.47	0.99	5.66	10.59	2.71	0.00	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.79	1.77	2.06	8.54	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	3.46	6.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.33	0.31	5.27	10.23	2.17	0.00	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.39	0.62	2.70	8.50	1.45	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	4.63	11.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.77	0.50	6.51	8.01	2.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.95	0.93	6.98	11.17	2.79	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.99	0.61	5.69	8.13	1.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.42	1.58	5.15	11.09	1.98	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	0.00	3.54	6.19	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.00	0.76	3.04	6.84	3.42	0.38	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.67	0.64	4.03	6.79	1.91	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	0.92	0.00	7.37	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.94	0.00	3.87	5.07	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	1.68	0.00	6.71	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.28	0.50	3.51	4.77	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.98	0.48	1.43	7.13	0.95	0.00	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	1.66	3.87	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.45	0.00	0.69	3.68	0.69	0.00	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.57	1.47	2.10	6.10	0.63	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.89	1.02	1.22	4.48	0.00	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	0.43	0.86	4.72	0.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.56	2.22	2.00	5.56	0.89	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.63	0.44	0.66	3.94	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	0.51	0.51	4.56	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	1.66	0.00	1.66	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.45	0.27	0.54	4.62	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.06	2.06	0.29	3.23	0.59	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	1.09	1.09	1.09	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.36	0.00	0.96	0.00	0.00	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.40	1.20	1.20	2.00	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	5.48	1.37	1.37	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	1.00	1.50	1.50	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.19	0.44	0.00	1.31	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	1.10	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.00	1.92	3.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.74	0.50	1.98	1.49	0.50	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	1.39	0.00	5.57	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	2.21	4.42	8.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	0.34	2.05	2.39	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.50	2.19	1.75	3.06	0.88	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.97	4.26	1.42	6.75	0.36	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.73	0.84	2.52	6.45	0.56	0.56	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.99	2.91	2.08	5.40	0.83	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.75	0.58	7.58	1.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.95	1.21	3.02	6.33	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	0.42	2.50	3.76	1.25	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	1.85	1.85	4.62	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	1.14	3.41	5.69	0.57	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.15	1.93	2.49	5.94	0.69	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.37	0.52	1.81	3.37	0.78	0.26	0.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.29	1.72	2.14	7.72	1.29	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	1.91	0.64	3.18	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.07	0.00	2.14	4.54	1.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.57	3.29	4.19	9.58	2.10	0.90	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.63	1.13	3.11	5.79	0.99	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.92	0.00	1.91	4.46	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.17	0.44	4.42	5.09	1.99	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.20	1.90	2.28	6.07	0.76	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.80	0.00	2.27	5.40	0.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.04	2.46	5.16	5.90	0.98	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	2.61	0.65	9.78	0.65	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	2.06	4.41	5.59	0.29	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.61	2.02	4.04	6.63	1.44	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.43	2.47	8.24	7.01	0.82	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.95	2.98	5.66	7.15	2.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	11.30	3.77	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	0.00	1.78	16.04	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	29.57	0.33	6.57	12.16	2.96	0.33	0.33	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	0.00	4.21	7.36	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.34	0.59	4.94	10.87	2.77	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	21.42	0.00	6.52	11.18	1.86	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.89	0.75	3.76	10.51	1.13	0.00	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.32	0.27	3.46	7.46	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.02	0.45	3.39	4.98	1.24	0.00	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	0.00	3.68	5.89	1.47	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.62	0.00	4.40	9.89	1.83	0.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	1.56	6.22	3.11	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.36	0.00	1.60	4.81	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	0.00	3.86	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	1.01	8.08	7.07	2.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.12	0.00	1.69	5.48	2.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	1.36	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.00	1.27	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	1.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	3.02	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	17.13	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	6.52	13.05	3.26	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	9.50	9.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	11.63	3.23	3.02	3.45	0.65	0.22	0.86	0.65	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.56	7.84	6.79	1.05	2.61	0.52	4.70	0.00	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	2.00	3.34	1.33	0.67	0.00	0.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.02	0.42	3.76	3.34	0.83	0.00	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	9.89	5.70	1.33	1.52	0.76	0.76	1.14	0.57	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	3.19	9.58	3.19	3.19	0.00	0.00	3.19	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	0.00	2.04	4.76	0.68	0.00	1.36	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	22.05	0.00	0.00	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.14	1.26	4.19	1.67	0.42	0.00	0.84	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.99	3.25	3.49	3.95	0.46	0.46	0.46	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.38	1.89	3.24	3.51	0.27	0.27	1.08	0.00	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.88	5.68	4.84	2.52	1.05	1.05	0.63	1.26	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	33.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.88	0.99	3.47	1.49	0.99	0.50	1.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.07	2.98	1.62	1.35	0.81	1.62	1.08	0.81	1.89
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.20	0.91	4.31	2.72	0.91	0.45	0.23	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.00	1.31	3.59	2.78	0.65	0.65	0.16	0.82	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	15.49	3.83	3.28	2.55	2.00	1.09	0.55	1.09	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	2.65	2.12	2.65	2.12	0.00	3.18	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	0.00	4.80	2.40	1.20	0.00	0.00	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.50	8.20	3.28	1.64	0.66	1.64	0.66	2.95	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.29	0.00	3.90	2.93	0.65	0.65	1.14	0.81	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.93	4.94	4.06	2.82	2.47	0.53	1.23	2.29	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	0.70	5.63	4.22	0.00	0.00	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.01	2.30	7.36	5.06	2.76	0.92	6.44	1.84	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.10	1.29	2.57	3.53	1.29	0.00	2.57	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	13.11	11.73	1.38	0.34	0.69	6.55	1.38	2.41	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	68.27	2.53	0.00	0.00	7.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.39	5.57	5.57	3.79	2.23	0.45	0.22	1.78	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.17	2.54	3.39	3.39	0.00	0.42	1.27	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.95	6.17	2.37	2.85	0.71	1.90	2.37	1.66	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	0.86	6.87	5.15	0.86	0.86	0.86	2.15	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	45.14	0.00	0.00	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.33	1.00	3.00	2.67	1.00	0.33	0.67	0.67	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	1.80	3.61	1.35	1.80	0.00	0.00	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	0.00	1.59	0.40	0.00	0.00	1.59	0.79	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	0.00	1.86	1.86	0.00	0.93	2.79	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	2.27	3.78	1.89	0.76	0.38	0.00	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.75	2.61	4.24	3.91	1.63	0.65	0.98	0.33	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.07	0.44	4.36	3.05	1.74	0.44	0.87	0.87	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.47	3.62	3.17	0.45	1.81	1.81	0.00	1.36	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	0.88	2.65	3.53	0.88	0.88	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	1.99	5.32	2.66	1.33	0.00	1.99	1.33	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	0.99	4.96	2.98	1.49	0.50	1.98	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.55	0.38	6.51	3.06	0.77	1.15	1.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	4.23	4.54	2.12	1.81	0.60	1.81	2.72	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.12	3.32	3.09	1.33	1.99	1.11	0.66	1.11	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.04	0.00	6.10	4.07	1.36	0.00	2.03	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	30.66	0.00	0.00	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.90	1.22	6.71	1.83	3.05	0.00	3.05	0.00	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	1.89	5.67	2.52	0.63	0.31	0.94	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	1.82	5.15	2.72	0.00	0.00	1.51	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	0.79	3.96	2.37	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	7.94	3.40	0.00	0.00	2.27	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	30.35	0.00	0.00	0.00	10.12	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	6.83	3.11	1.49	3.23	0.62	0.87	0.37	0.12	0.00
Myoblast, donor2	11322-117D8	11.12	4.79	6.71	3.07	0.58	1.92	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	10.09	3.70	4.71	2.69	2.52	1.18	0.00	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	14.59	10.22	8.46	9.78	2.33	1.90	0.58	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	49.51	4.00	6.46	57.20	1.23	0.92	0.31	2.77	1.85
Natural Killer Cells, donor2	11311-117C6	48.25	5.43	9.05	57.30	3.32	0.60	0.30	2.71	0.30
Natural Killer Cells, donor3	11387-118C1	50.80	4.05	8.10	61.66	3.68	1.29	2.21	2.94	0.92
Neural stem cells, donor1	11275-116H6	27.58	4.72	3.27	6.17	3.27	7.62	0.73	0.00	0.00
Neural stem cells, donor2	11352-117H2	55.84	28.88	15.41	7.70	7.70	21.18	7.70	1.93	3.85
Neurons, donor1	11494-119E9	47.79	20.48	10.24	3.41	3.41	11.38	2.28	5.69	1.14
Neurons, donor2	11574-120E8	51.30	21.58	10.79	3.08	4.84	14.97	5.28	1.98	3.96
Neurons, donor3	11655-122E8	44.40	10.69	4.93	1.64	5.76	3.29	0.00	1.64	2.47
Neutrophils, donor1	11233-116C9	12.06	4.64	6.50	25.06	1.86	2.78	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	5.80	5.80	43.48	5.80	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	21.38	13.44	6.11	38.48	0.61	4.89	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	11.52	8.67	3.80	2.97	2.37	3.56	0.95	1.66	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	6.51	5.86	4.23	1.30	1.63	1.30	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	4.01	5.01	1.60	0.40	0.60	0.40	0.40	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	30.83	1.24	6.19	2.48	3.99	0.14	0.83	0.83	0.41
Olfactory epithelial cells, donor2	11934-125I8	23.88	2.03	5.93	2.17	1.45	0.43	0.58	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	25.54	1.02	6.70	1.36	3.75	0.45	0.57	0.79	0.34
Olfactory epithelial cells, donor4	11936-126A1	25.42	1.07	8.18	1.66	3.21	0.29	0.78	0.78	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	10.83	6.02	6.02	3.01	4.21	1.81	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.97	6.17	3.83	1.91	1.28	3.19	0.64	2.13	0.85
Osteoblast - differentiated, donor2	11353-117H3	14.86	2.29	3.43	2.29	1.14	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.79	3.72	4.97	4.34	1.24	0.62	0.00	1.24	0.00
Osteoblast, donor1	11277-116H8	13.29	14.46	5.28	3.13	0.98	3.71	0.59	1.76	1.56
Osteoblast, donor2	11354-117H4	7.02	16.15	5.62	1.40	0.70	2.11	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	10.13	9.42	6.40	4.44	1.42	1.78	0.18	0.36	0.36
Pancreatic stromal cells, donor1	11249-116E7	14.15	5.48	5.31	2.36	2.19	1.01	1.52	0.67	0.42
Pericytes, donor1	11491-119E6	38.50	8.12	7.34	3.89	3.45	1.89	2.00	2.34	1.45
Pericytes, donor2	11571-120E5	31.69	6.79	7.92	4.98	3.62	2.72	0.91	2.26	1.81
Pericytes, donor3	11652-122E5	10.17	7.12	5.09	3.87	1.42	1.22	1.02	0.41	0.61
Perineurial Cells, donor1	11499-119F5	7.35	5.99	4.97	2.15	1.58	1.24	1.13	0.34	0.90
Perineurial Cells, donor2	11579-120F4	6.62	5.52	4.88	3.77	1.84	1.38	0.28	0.28	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	41.12	4.78	10.20	53.55	2.55	1.91	0.64	0.96	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.87	2.94	6.61	33.06	1.47	0.98	0.24	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	40.77	6.86	9.45	44.26	2.07	2.20	1.29	1.29	1.29
Placental Epithelial Cells, donor1	11278-116H9	9.09	3.83	5.02	1.67	2.15	1.67	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	11.09	1.11	4.44	1.11	3.33	4.44	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	9.23	6.09	9.62	2.75	2.55	2.36	0.79	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	1.90	3.48	1.58	0.00	0.00	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	17.26	3.75	3.19	2.44	2.06	0.56	0.38	0.94	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.71	3.26	13.44	2.74	6.79	1.83	0.78	0.39	1.31
Preadipocyte - breast, donor2	11328-117E5	16.44	3.15	4.73	2.03	2.93	0.68	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	16.62	4.48	3.09	1.28	1.92	0.75	0.32	0.53	0.43
Preadipocyte - omental, donor2	11329-117E6	11.35	3.93	2.62	2.18	4.80	0.00	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	18.19	3.15	5.87	3.72	2.86	0.72	0.72	0.29	0.57
Preadipocyte - perirenal, donor1	11469-119C2	10.83	1.97	1.97	0.98	0.98	0.00	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	14.74	6.76	5.53	1.84	0.92	1.23	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	11.33	4.25	5.14	3.72	0.53	0.53	0.71	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	12.43	4.94	3.07	1.53	1.02	0.68	0.17	0.17	0.68
Preadipocyte - visceral, donor1	11280-116I2	7.45	5.87	1.77	1.96	0.75	0.84	0.47	0.19	0.28
Preadipocyte - visceral, donor2	11357-117H7	6.90	3.22	3.22	0.92	2.30	1.84	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	7.21	2.40	1.67	1.57	0.73	0.42	0.63	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.13	6.64	2.41	0.45	1.36	4.68	0.00	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	12.05	19.77	4.33	1.62	1.76	7.45	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	7.47	8.02	3.74	1.22	1.29	1.35	0.18	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	9.11	5.70	3.30	1.48	1.03	1.71	0.34	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	7.17	4.48	2.15	2.33	1.26	2.69	1.08	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	17.52	5.01	6.78	2.19	2.40	2.19	0.63	0.83	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.47	7.66	4.38	3.28	2.55	2.92	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.57	7.69	3.81	1.39	0.97	2.01	0.14	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	8.12	11.67	7.10	2.03	2.03	3.55	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	9.96	0.71	0.00	2.13	2.13	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.26	8.26	4.23	1.91	1.80	2.01	0.21	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	8.17	2.04	27.23	1.36	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.79	4.45	1.35	15.63	0.27	0.67	0.00	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.77	8.88	3.11	13.10	0.44	1.11	0.67	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	4.66	3.33	40.59	2.66	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.68	13.43	4.84	4.18	2.42	1.76	0.00	0.44	0.44
Renal Mesangial Cells, donor2	11598-120H5	15.67	9.40	6.90	3.13	4.39	1.25	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	14.98	9.71	9.99	1.94	4.16	2.77	0.55	0.55	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.64	5.37	4.29	1.34	2.68	0.81	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	4.22	3.37	1.27	0.84	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.68	10.80	5.59	1.16	2.89	2.31	0.96	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.37	5.70	5.44	1.56	2.33	2.07	1.04	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.14	11.94	12.22	1.71	6.54	2.27	0.57	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	7.20	10.29	1.03	1.03	2.06	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	39.89	3.26	4.52	2.76	4.01	3.01	0.75	1.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	18.31	4.14	10.29	7.75	4.14	1.47	0.67	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.93	3.57	1.79	0.89	0.00	0.89	1.79	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.01	4.95	2.20	1.10	0.55	1.10	1.65	0.55	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.02	5.22	5.22	1.74	1.16	1.74	1.16	0.58	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.03	5.07	4.29	1.17	2.86	1.30	0.65	0.52	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.46	3.08	5.66	1.79	2.28	0.89	0.99	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.53	4.24	7.58	2.34	3.23	1.23	0.89	0.33	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	17.12	6.08	5.58	0.62	4.09	1.98	0.37	0.87	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	19.81	3.85	9.44	1.52	3.26	1.28	0.93	0.35	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.49	3.70	9.71	0.92	3.00	0.69	1.62	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	12.87	2.60	6.43	1.64	3.29	0.41	1.23	0.27	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	15.28	3.48	8.93	1.51	2.27	1.21	0.61	0.61	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.80	3.05	7.17	1.79	1.08	1.43	0.90	1.08	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	16.50	4.45	7.89	1.43	2.30	0.57	1.29	0.29	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.45	3.97	7.19	1.40	1.93	0.75	1.50	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	19.03	3.10	9.51	3.32	3.54	1.11	0.89	0.66	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.76	3.06	3.44	1.53	1.53	0.19	1.34	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.05	3.82	7.17	1.30	1.96	1.30	0.37	0.28	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.80	2.82	8.64	1.50	2.07	3.01	1.13	0.56	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.74	5.57	6.37	0.93	2.52	0.66	0.66	0.40	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.62	4.48	7.01	1.46	3.60	1.65	0.78	0.58	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	22.92	3.06	9.93	1.72	3.44	1.34	1.53	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	15.49	3.63	5.45	1.28	1.92	0.75	0.43	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.26	3.36	5.89	0.56	1.40	0.56	0.56	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.00	3.76	9.91	1.03	3.08	1.03	0.85	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.40	3.46	4.92	2.19	1.64	1.09	1.09	0.55	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.60	3.80	9.57	2.08	2.33	1.47	0.74	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.73	5.64	8.73	2.15	2.96	1.48	0.40	0.27	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.21	4.01	2.83	1.89	2.36	0.24	0.47	0.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.06	4.37	7.34	2.18	2.78	1.19	1.59	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	16.84	3.04	6.78	1.87	2.81	2.34	0.94	0.94	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	14.31	3.11	3.94	1.24	1.24	0.41	0.83	0.21	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	15.48	3.32	4.65	1.33	2.21	1.11	1.11	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.50	4.60	6.68	2.72	2.30	1.25	1.04	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.27	4.31	6.33	1.75	1.08	0.81	1.08	0.27	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	12.60	4.09	4.77	1.70	0.85	1.53	1.02	0.17	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	20.24	4.24	6.94	2.12	1.35	1.93	0.58	0.96	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.99	5.33	8.25	1.20	2.06	0.34	1.03	0.17	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	14.68	6.31	7.82	2.33	1.23	3.29	0.96	0.41	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	15.92	5.25	8.54	1.64	2.63	1.97	1.15	0.16	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.17	3.92	3.92	1.36	1.36	0.00	1.53	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	23.38	5.77	8.73	1.92	1.63	1.92	0.59	0.15	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.13	2.93	6.93	1.87	2.93	0.80	1.33	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.93	5.39	4.29	1.52	1.80	1.11	1.80	0.97	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	13.81	3.81	7.38	1.43	0.95	1.67	0.48	0.00	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	21.77	5.64	11.69	2.02	3.63	1.81	2.82	1.81	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	10.45	4.61	6.40	0.85	2.83	1.60	1.04	0.28	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	14.67	4.19	9.43	2.79	1.75	2.10	1.40	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.00	3.32	3.93	3.32	0.60	1.51	1.51	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.65	4.53	4.90	1.71	2.45	1.71	0.98	0.49	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	24.74	8.30	8.30	2.47	3.20	4.22	2.62	0.44	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.21	4.26	7.30	1.83	0.00	0.61	2.43	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	7.84	3.62	3.62	0.90	0.90	0.00	1.81	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.83	5.20	7.46	2.04	1.58	2.04	1.81	0.68	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.07	7.19	7.19	2.10	3.59	3.29	2.40	1.50	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	16.18	6.97	3.90	2.01	1.65	2.24	2.13	0.94	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.30	7.47	6.40	3.42	1.92	2.77	2.35	0.85	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.03	6.61	7.81	1.80	0.60	1.20	1.80	0.00	1.20
Schwann Cells, donor1	11498-119F4	6.02	7.71	6.39	1.88	2.26	0.75	1.32	0.75	1.13
Schwann Cells, donor2	11578-120F3	0.00	0.00	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.76	4.60	7.23	2.85	1.10	1.31	1.75	0.44	0.66
Sebocyte, donor1	11220-116B5	14.79	21.36	7.67	2.74	2.74	6.57	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	12.41	16.08	6.89	0.92	3.22	5.51	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	9.28	11.13	6.39	2.06	1.24	1.44	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	16.57	8.28	1.66	4.97	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	8.47	2.82	5.65	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.38	8.80	3.61	1.76	0.79	2.99	0.62	0.53	0.18
Skeletal Muscle Cells, donor2	11358-117H8	10.12	2.89	4.34	3.61	0.00	1.45	1.45	2.89	0.72
Skeletal Muscle Cells, donor3	11430-118G8	6.69	18.39	13.38	1.67	1.67	3.34	1.67	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	4.56	5.50	3.14	2.04	0.47	0.47	0.63	1.10	0.31
Skeletal Muscle Cells, donor5	11455-119A6	4.61	4.61	2.38	1.64	0.45	0.30	0.59	0.59	0.45
Skeletal Muscle Cells, donor6	11459-119B1	4.31	4.92	3.39	1.23	0.15	0.46	0.62	0.15	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	7.94	10.96	4.28	3.53	1.13	1.64	1.51	0.50	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	8.85	6.99	5.14	3.71	1.57	0.43	0.86	1.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.85	6.65	5.75	1.79	1.88	1.69	0.10	0.30	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	15.42	6.66	2.78	2.02	1.60	3.29	0.84	1.35	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.79	12.30	8.69	1.45	2.90	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.67	7.43	3.58	3.16	0.69	1.51	0.55	0.41	0.55
Skin - palm, donor1	10286-104F7	67.15	64.47	29.55	2.69	5.37	13.43	5.37	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.46	7.06	1.59	2.16	0.72	0.86	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	40.08	69.52	6.54	8.18	2.45	2.45	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.54	7.53	1.95	2.73	0.52	0.65	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	5.70	12.79	2.64	2.92	0.28	2.50	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	5.49	11.25	3.09	3.52	0.98	1.13	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	31.08	75.06	23.68	9.73	12.48	12.48	0.42	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	6.75	15.89	3.75	1.42	1.20	2.55	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.89	4.01	3.39	0.93	1.54	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.23	11.34	3.33	2.67	3.56	2.22	0.00	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	6.47	7.05	4.11	2.94	1.76	1.76	0.00	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.62	4.86	1.77	5.52	0.44	3.09	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.88	5.12	2.76	3.54	1.58	2.36	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.04	10.04	3.09	6.95	1.55	1.55	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	39.03	2.00	3.00	7.01	5.00	1.00	1.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.51	5.19	4.92	6.12	1.60	1.73	0.00	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.75	2.66	3.32	2.66	2.22	1.55	0.00	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.25	3.33	3.20	4.48	0.64	1.54	0.13	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.65	3.91	4.23	2.28	0.65	1.30	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.63	3.54	6.50	3.25	2.66	1.77	1.48	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.81	1.99	4.98	2.85	1.85	0.28	0.71	0.71	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.32	6.51	4.55	2.77	1.63	1.79	0.81	0.33	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	8.22	7.31	3.65	2.13	2.74	2.13	1.52	1.52	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.63	4.04	1.77	2.53	1.77	1.26	0.51	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	18.36	6.12	36.72	6.12	6.12	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.63	4.29	4.29	3.34	1.43	1.91	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.36	3.10	3.83	2.65	1.03	1.03	0.88	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.39	5.17	3.66	1.08	1.08	0.86	0.22	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.77	5.88	4.62	1.36	0.94	0.84	0.10	0.73	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.66	6.96	3.25	4.80	1.86	2.17	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	5.39	3.23	5.39	2.16	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.38	0.90	2.99	2.09	0.90	0.30	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.24	6.49	7.17	1.71	1.71	0.68	1.02	1.71	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.27	7.93	8.64	1.57	3.06	2.12	1.18	1.10	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.92	5.33	2.82	3.52	1.11	2.82	0.30	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.51	4.10	1.59	2.73	0.46	0.91	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	2.42	1.21	1.21	3.02	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	9.54	9.01	6.62	1.32	1.59	2.12	0.79	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.19	4.39	3.60	1.86	1.46	0.80	0.40	0.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.78	6.39	4.88	2.50	2.13	2.00	0.25	0.38	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	14.46	1.27	6.34	2.54	3.55	1.78	1.27	0.76	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	9.35	6.78	1.66	4.22	0.30	1.66	0.75	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	7.50	2.25	3.00	0.75	1.50	0.00	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	3.88	3.88	32.31	1.29	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.95	9.77	2.33	3.26	1.40	4.19	1.40	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.10	1.51	1.51	8.58	0.50	1.01	1.51	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.46	5.64	2.51	2.51	0.31	2.51	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.44	5.90	2.36	2.65	0.88	1.18	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	6.33	6.50	6.08	2.75	1.75	1.58	0.42	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.28	2.80	4.20	1.87	1.87	1.40	0.47	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.48	4.75	2.30	5.76	0.58	1.73	0.14	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.16	7.14	6.37	8.67	0.76	1.27	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.59	3.57	2.82	6.39	1.13	0.75	0.56	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	6.29	7.55	3.07	2.38	1.54	1.12	0.00	0.28	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.44	3.18	3.60	2.26	1.59	0.50	0.08	0.59	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	2.38	1.90	2.86	1.90	0.00	0.48	0.95	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	4.40	3.67	4.65	0.98	1.47	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.51	4.20	1.55	1.10	0.44	0.44	0.22	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.90	3.22	3.22	2.05	0.29	1.17	0.00	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.91	1.94	4.66	0.78	1.17	1.17	1.75	2.92	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.54	3.44	1.85	1.06	0.26	0.26	0.53	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.02	7.07	1.49	0.00	1.49	1.49	1.86	1.49	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	18.69	6.83	3.95	2.52	2.52	1.80	1.08	1.08	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.79	7.38	1.99	3.69	0.28	0.28	0.28	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.21	3.15	1.18	1.97	0.00	0.79	1.18	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	16.25	3.05	1.52	1.02	0.51	0.76	0.76	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	9.58	3.99	2.40	0.40	0.80	0.40	0.80	2.40	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	17.14	2.51	2.09	0.84	1.25	0.42	1.67	2.93	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	4.13	2.75	0.00	0.46	0.46	2.75	1.38	0.00
Synoviocyte, donor1	11291-117A4	12.46	1.51	1.01	1.85	1.68	0.84	0.50	0.34	0.00
Synoviocyte, donor2	11368-117I9	11.06	3.18	4.69	2.18	1.68	1.01	0.34	0.34	0.34
Synoviocyte, donor3	11440-118H9	12.29	1.79	3.57	2.01	1.56	0.45	0.00	0.22	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	6.79	10.36	4.29	1.79	1.79	5.00	0.71	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	9.91	5.95	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.95	10.88	8.10	2.78	1.62	3.47	0.23	0.93	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	6.24	12.97	3.37	1.58	0.43	1.36	0.07	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	5.03	17.40	8.89	2.71	2.32	1.55	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	6.87	2.29	0.57	2.86	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.93	2.95	10.83	7.75	4.80	1.60	0.25	0.49	0.25
Urethra, donor2	10319-105A4	43.16	8.99	16.19	5.40	5.40	5.40	5.40	5.40	0.00
Urothelial Cells, donor1	11520-119H8	2.92	17.53	3.98	2.13	1.59	2.39	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	6.41	17.22	4.81	1.20	2.40	1.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.73	18.79	5.04	0.92	1.38	0.92	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	6.02	11.59	6.46	2.23	1.11	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	34.70	9.79	9.79	35.59	5.34	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	1.43	1.43	40.03	1.43	0.00	5.72	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	10.95	12.32	36.28	8.21	1.37	3.42	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	31.68	5.51	5.17	36.50	3.44	1.72	1.38	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	34.86	5.23	6.39	41.25	4.07	1.16	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	24.99	6.25	3.12	32.28	0.00	2.08	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	8.26	5.51	28.45	4.59	0.92	2.75	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	25.56	3.65	9.13	37.43	2.74	2.74	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	40.83	7.77	14.80	3.08	7.15	3.70	0.37	0.37	0.74
Wilms' tumor cell line:HFWT	10597-108E3	3.52	12.32	5.28	0.00	3.52	7.92	4.40	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	6.42	16.48	8.94	0.56	2.23	1.68	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	12.40	0.00	24.80	10.33	6.20	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.45	2.55	10.20	7.14	4.59	1.78	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.14	8.59	11.84	8.82	3.71	3.48	0.70	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	10.92	16.14	13.41	9.62	3.32	5.70	1.66	4.87	3.09
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.16	9.25	4.63	14.97	2.45	3.27	2.45	1.36	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	30.36	5.62	6.18	21.92	5.90	1.12	1.12	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.96	18.40	8.46	22.42	2.75	5.08	1.48	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.13	16.06	10.62	26.40	3.27	3.81	0.27	0.00	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	30.40	11.02	17.18	28.64	10.58	3.97	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	44.10	8.17	9.80	34.71	8.58	0.82	2.45	2.45	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.91	19.03	19.41	38.05	5.05	5.82	5.82	2.33	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.35	3.13	8.46	10.86	3.13	0.37	1.47	0.00	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	85.81	31.20	62.41	0.00	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.80	18.36	7.44	9.53	2.32	3.02	0.23	0.23	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	14.50	10.87	6.99	3.37	2.33	2.59	0.00	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.43	5.26	9.06	8.77	0.88	1.46	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	8.37	6.51	9.30	9.30	1.86	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	8.23	1.65	2.88	5.76	0.82	0.82	0.82	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.14	1.53	5.53	6.75	0.61	1.23	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	7.25	3.41	3.41	4.69	2.13	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	5.46	2.73	4.25	5.76	0.30	0.91	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.39	5.30	3.61	3.37	2.41	1.44	0.00	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.15	4.68	10.02	25.39	4.23	1.56	0.22	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.67	15.01	1.67	4.67	1.00	2.67	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	366.07	20.44	1.86	1.86	9.29	1.86	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.96	66.67	10.92	17.70	3.39	5.27	1.88	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.71	61.06	9.16	45.79	5.23	10.03	2.62	0.87	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	181.82	9.37	26.24	0.00	15.00	1.87	1.87	3.75
adenocarcinoma cell line:IM95m	10796-110I4	6.83	4.00	5.42	0.24	1.88	1.65	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	13.34	1.55	5.27	7.76	1.55	0.00	0.93	0.31	0.31
adipose, donor1	10184-103D4	9.97	46.91	5.28	0.00	5.28	11.14	0.00	0.00	0.59
adipose, donor2	10185-103D5	33.66	3.65	12.17	2.43	4.87	3.65	0.41	1.22	0.41
adipose, donor3	10186-103D6	31.04	15.25	8.71	20.15	5.17	4.08	1.36	0.54	0.82
adipose, donor4	10187-103D7	41.60	10.40	4.33	57.21	1.73	6.93	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.15	11.52	22.25	3.79	3.31	2.37	1.42	0.79	0.95
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	10.91	0.00	3.64	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.87	4.80	13.74	4.14	2.80	0.93	0.53	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	14.29	5.00	7.15	0.71	3.22	2.14	0.00	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	11.82	4.41	8.35	0.93	2.55	0.46	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	27.72	4.40	14.54	5.07	7.78	1.35	0.34	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	16.20	4.42	7.07	1.18	4.12	1.18	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	45.06	0.00	4.74	4.74	7.11	0.00	7.11	0.00	5.93
amygdala, adult, donor10252	10151-102I7	49.27	3.65	13.79	3.85	8.92	1.62	1.42	2.23	2.23
amygdala, newborn, donor10223	10360-105E9	44.54	0.97	4.84	4.20	1.29	0.65	4.84	0.97	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	10.57	5.09	4.84	3.44	2.55	1.66	0.76	0.76	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	11.69	4.85	11.91	7.72	2.87	1.32	0.22	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	19.37	22.38	15.37	0.67	5.68	14.36	0.00	1.34	0.67
aorta, adult, pool1	10052-101G7	32.75	0.39	18.83	4.51	9.22	0.00	0.59	3.53	0.78
appendix, adult	10189-103D9	33.77	5.82	13.97	24.84	1.16	0.39	1.94	3.10	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.25	7.22	4.82	3.10	3.10	3.78	0.34	0.34	0.34
artery, adult	10190-103E1	25.82	0.00	6.79	2.72	5.43	0.00	0.00	5.43	0.00
astrocytoma cell line:TM-31	10425-106D2	25.79	8.26	6.81	3.48	6.52	1.88	0.87	0.29	0.29
b cell line:RPMI1788	10427-106D4	8.48	8.18	7.58	7.44	1.19	2.08	0.15	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	7.77	5.55	3.05	3.88	2.22	0.83	0.55	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.63	6.25	3.77	1.89	1.29	1.29	0.10	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	2.18	1.51	1.84	0.00	0.17	0.67	0.00	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.05	3.36	5.59	11.74	1.68	2.24	2.24	0.00	0.56
bladder, adult, pool1	10011-101C2	25.20	1.52	10.43	2.61	12.06	0.76	1.30	1.85	1.20
blood, adult, pool1	10053-101G8	15.50	0.00	4.43	33.22	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	5.99	1.71	3.43	1.71	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	20.24	0.00	5.40	4.05	0.67	0.67	2.02	0.67	0.67
brain, adult, donor1	10084-102B3	70.73	0.00	9.23	11.28	2.05	1.03	3.08	3.08	4.10
brain, adult, pool1	10012-101C3	65.26	1.56	6.79	7.91	3.90	0.33	2.45	0.56	2.56
brain, fetal, pool1	10085-102B4	98.84	10.69	10.69	8.01	5.34	2.67	10.69	0.00	21.37
breast carcinoma cell line:MCF7	10482-107A5	26.43	12.22	10.24	2.31	2.31	4.63	0.00	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.20	3.62	8.61	1.87	4.99	2.25	0.62	0.12	0.25
breast, adult, donor1	10080-102A8	8.21	0.00	10.10	5.68	3.16	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.53	6.61	9.40	1.14	4.95	4.07	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.91	2.78	6.18	1.24	1.24	0.62	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.92	6.91	1.15	0.00	0.23	1.61	0.00	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.12	3.15	5.57	0.24	0.97	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	3.29	8.93	9.87	0.00	0.94	0.47	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	4.48	5.36	3.39	0.98	0.98	1.97	0.00	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	8.56	8.87	0.00	2.54	0.63	0.00	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.71	10.11	8.52	1.33	1.33	4.53	1.33	3.73	1.60
caudate nucleus - adult, donor10196	10177-103C6	49.51	8.06	11.51	2.30	10.36	0.00	6.91	0.00	14.97
caudate nucleus, adult, donor10252	10164-103B2	54.55	5.35	11.04	4.69	11.38	1.67	1.51	1.84	3.18
caudate nucleus, adult, donor10258	10379-105H1	74.89	1.53	8.41	9.17	7.64	0.00	6.88	1.53	6.88
caudate nucleus, newborn, donor10223	10354-105E3	49.81	4.76	3.66	3.30	3.30	2.56	10.25	2.56	13.18
cerebellum - adult, donor10196	10173-103C2	69.92	2.91	0.00	2.91	11.65	0.00	5.83	0.00	11.65
cerebellum, adult, donor10252	10166-103B4	85.40	2.56	17.29	1.92	11.74	2.14	4.48	1.92	3.63
cerebellum, adult, pool1	10083-102B2	58.30	1.03	6.90	5.52	3.45	1.72	2.41	0.69	1.38
cerebellum, newborn, donor10223	10357-105E6	48.16	20.76	4.15	1.66	1.66	8.30	4.15	2.49	0.83
cerebral meninges, adult	10188-103D8	55.97	2.77	8.07	6.05	3.28	1.26	2.52	1.01	2.27
cerebrospinal fluid, donor2	10294-104G6	17.54	5.85	8.04	13.89	2.92	0.73	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	11.07	1.44	5.46	0.72	4.03	0.58	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	6.96	12.10	5.47	0.66	1.82	3.48	0.17	0.17	0.00
cervix, adult, pool1	10013-101C4	56.17	3.57	15.64	5.35	11.97	0.94	3.46	4.51	2.20
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	15.05	2.51	5.71	3.48	2.79	1.95	0.14	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	1.31	2.61	5.23	10.45	1.31	1.31	0.00	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	2.86	7.21	4.60	0.50	1.24	2.73	0.12	0.12	0.50
choriocarcinoma cell line:SCH	10785-110H2	12.57	3.94	18.36	0.74	3.33	1.36	0.25	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	0.95	5.93	3.56	0.24	0.47	1.66	0.24	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	6.55	1.99	11.11	2.85	1.71	0.28	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	12.53	6.26	7.76	1.09	4.67	1.99	0.40	0.50	0.20
chorionic membrane cells, donor3	12240-129G8	8.24	3.30	9.89	3.30	2.20	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	4.04	4.04	11.11	1.01	1.01	2.02	4.04	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.37	5.19	7.49	22.48	2.88	2.31	0.19	0.38	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	66.52	110.87	13.30	26.82	5.28	14.36	1.06	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.57	36.47	8.73	0.00	3.85	3.08	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	4.35	45.47	9.68	0.97	4.35	5.56	0.24	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	4.28	34.61	9.16	0.41	4.89	4.28	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	6.18	44.76	5.89	0.59	3.24	10.01	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	38.31	164.45	7.56	16.68	3.91	17.20	0.00	0.26	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.91	5.03	4.80	2.29	2.06	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	10.58	3.47	4.68	0.87	2.43	0.35	0.35	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	5.86	5.49	4.58	0.00	1.28	2.75	0.00	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	9.50	6.84	11.78	0.76	7.98	3.04	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	20.23	3.57	8.33	7.14	14.28	1.19	1.19	0.00	2.38
colon, adult, pool1	10014-101C5	21.62	3.41	10.11	5.17	6.93	1.65	0.47	1.06	0.24
colon, fetal, donor1	10070-101I7	19.16	1.24	14.83	7.42	6.18	0.62	6.18	1.85	3.71
common myeloid progenitor CMP, donor1	12130-128D6	132.92	220.01	27.50	123.76	18.33	45.84	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.82	1.27	2.12	2.97	2.12	5.10	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.28	2.26	2.72	6.34	1.66	2.72	0.75	0.15	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	6.91	2.82	2.68	5.22	1.27	1.41	0.85	0.14	0.71
corpus callosum, adult, pool1	10042-101F6	81.37	1.44	10.17	9.51	11.28	1.11	1.22	0.55	1.33
cruciate ligament, donor2	10295-104G7	22.69	5.67	8.92	17.83	3.24	0.00	4.05	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	14.45	3.21	7.22	3.21	8.03	0.00	0.80	0.80	4.01
diencephalon, adult	10193-103E4	39.12	2.16	6.72	3.84	5.76	0.96	2.16	1.20	2.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.25	7.81	8.50	8.73	1.61	0.92	0.92	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	14.36	1.54	0.77	1.03	3.33	0.26	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2.65	5.54	2.65	0.00	0.48	1.44	0.48	0.48	0.00
ductus deferens, adult	10196-103E7	49.83	1.00	9.97	7.48	8.97	1.00	1.50	1.00	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	2.88	12.96	8.64	2.88	0.00	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	5.89	9.56	8.09	5.15	3.68	2.94	3.68	2.21
dura mater, adult, donor1	10041-101F5	49.97	3.22	10.90	14.70	5.45	0.58	1.49	1.07	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	7.11	10.22	4.44	0.22	1.11	3.11	0.67	0.44	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	8.60	7.74	3.87	0.57	0.86	3.73	0.29	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	3.08	4.32	4.93	1.23	1.85	2.47	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	4.54	2.42	3.63	0.91	1.21	1.21	0.30	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	3.40	3.09	2.47	1.23	0.62	0.31	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	3.94	3.94	6.57	1.31	1.31	5.25	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	10.39	7.37	4.02	0.67	2.35	3.69	0.00	0.00	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.42	5.98	3.62	1.99	1.63	4.71	1.27	0.36	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	11.26	10.29	12.70	1.45	1.93	3.38	0.48	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	7.45	12.12	2.78	0.44	1.00	2.00	0.11	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.37	9.57	5.39	0.66	2.20	1.98	0.00	0.00	0.33
epididymis, adult	10197-103E8	35.16	2.93	10.88	4.60	4.81	1.05	0.84	1.88	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.16	4.79	4.97	1.42	0.89	1.24	0.89	0.53	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.91	0.79	3.54	8.65	2.36	1.57	1.18	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	6.55	4.46	10.75	0.39	4.85	1.70	0.26	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	5.71	4.23	9.05	0.49	1.67	1.97	0.30	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.71	4.93	10.42	0.78	3.81	1.34	0.11	0.00	0.11
esophagus, adult, pool1	10015-101C6	21.24	8.07	7.01	4.03	4.78	1.49	0.32	0.74	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	23.92	11.27	6.26	3.38	2.50	7.76	2.38	2.50	2.50
eye - muscle inferior rectus, donor1	10272-104E2	26.56	0.00	28.97	4.83	12.07	2.41	2.41	7.24	4.83
eye - muscle lateral, donor2	10298-104H1	10.52	6.31	31.56	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	1.49	5.95	2.98	1.49	1.49	0.00	4.46	4.46
eye - muscle superior, donor2	10297-104G9	16.05	1.15	8.03	4.59	4.59	0.00	1.15	1.15	4.59
eye - vitreous humor, donor1	10268-104D7	21.86	4.37	7.29	4.37	0.00	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	47.03	3.56	9.66	4.58	7.37	0.51	2.03	1.53	2.80
fibrosarcoma cell line:HT-1080	10758-110E2	2.82	2.18	3.33	4.23	1.28	0.90	0.26	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.11	6.65	4.99	3.32	0.95	0.71	0.24	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	86.22	2.16	5.63	7.98	5.72	0.94	4.22	2.25	5.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	10.21	4.80	2.70	0.60	1.80	2.70	0.30	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	4.57	1.55	3.93	0.82	2.29	1.37	0.09	0.37	0.27
gall bladder, adult	10198-103E9	42.73	1.69	12.31	8.93	7.24	0.72	4.59	3.38	2.90
gamma delta positive T cells, donor1	11937-126A2	24.70	3.76	4.83	41.34	5.91	1.07	0.00	0.54	1.61
gamma delta positive T cells, donor2	11938-126A3	40.71	2.61	7.47	29.51	1.87	0.37	1.12	1.87	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.45	5.70	2.32	0.42	1.27	1.27	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.03	11.41	4.64	0.19	1.55	4.06	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	16.40	6.07	17.54	1.64	6.39	2.62	1.97	0.82	0.66
gastric cancer cell line:GSS	10560-108A2	0.92	0.92	3.66	1.83	1.83	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	11.88	2.97	6.40	0.91	0.91	0.91	0.91	0.46	0.69
giant cell carcinoma cell line:LU65	10487-107B1	1.26	1.03	1.38	0.00	0.69	0.23	0.11	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	15.96	7.56	7.84	1.12	1.12	0.98	0.42	0.56	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	16.96	9.48	6.48	1.25	3.24	1.25	0.75	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.35	8.34	3.91	1.58	1.58	5.28	0.32	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	12.08	7.02	6.18	2.39	1.97	3.51	1.12	0.28	0.42
glioblastoma cell line:T98G	10485-107A8	13.80	3.31	3.64	2.32	2.54	0.66	0.44	0.99	0.33
glioma cell line:GI-1	10413-106B8	22.55	7.03	6.15	2.34	5.86	4.98	0.29	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	40.09	0.73	7.29	1.46	7.29	0.00	6.56	0.73	4.37
globus pallidus, adult, donor10252	10161-103A8	45.16	4.88	20.75	4.64	21.24	1.22	2.20	0.98	1.22
globus pallidus, adult, donor10258	10367-105F7	49.29	1.37	9.58	2.74	8.22	1.37	2.74	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	30.91	1.07	3.20	2.13	2.13	1.07	5.33	1.60	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	41.60	22.02	78.31	19.58	14.68	0.00	4.89	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	43.71	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.40	8.64	2.88	0.32	0.32	0.64	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	7.35	6.89	8.72	0.92	3.21	1.84	0.00	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	7.32	5.94	3.66	1.37	2.29	0.91	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.22	3.86	1.93	0.00	1.29	1.29	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	8.62	1.44	2.87	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	6.17	4.80	4.80	0.69	0.69	1.37	0.00	1.37	0.00
hIPS, biol_rep3	14382-156B8	41.93	0.00	1.10	2.21	5.52	0.00	0.00	1.10	3.31
hairy cell leukemia cell line:Mo	10712-109I1	10.63	26.44	6.90	14.37	1.72	1.72	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	22.42	0.30	9.57	5.68	5.68	0.00	1.49	1.49	0.90
heart - pulmonic valve, adult	10206-103F8	45.24	0.52	10.72	6.54	12.03	0.52	1.57	1.83	1.05
heart - tricuspid valve, adult	10207-103F9	7.49	5.00	5.00	3.33	3.33	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	27.55	2.86	15.92	4.29	11.43	0.41	0.82	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	25.12	0.43	17.03	4.68	15.76	0.00	1.28	0.85	0.85
heart, adult, pool1	10016-101C7	12.65	1.15	6.44	4.14	9.66	0.00	0.92	0.92	0.00
heart, fetal, pool1	10046-101G1	35.22	3.90	24.03	7.19	21.56	1.33	2.16	1.85	1.95
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	2.47	8.02	4.94	2.78	0.62	0.62	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	2.38	21.41	2.38	0.00	0.00	8.32	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	2.98	7.07	3.87	0.44	2.43	4.31	0.00	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	4.73	9.47	4.13	0.00	2.06	5.83	0.24	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	4.04	9.09	4.75	0.20	1.72	5.15	0.10	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	21.24	5.00	10.12	0.89	6.12	1.33	0.22	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.18	4.72	10.85	6.43	1.81	1.41	0.40	0.30	0.30
hippocampus - adult, donor10196	10169-103B7	29.34	1.89	9.46	3.79	4.73	0.95	5.68	0.00	4.73
hippocampus, adult, donor10252	10153-102I9	44.09	4.90	20.61	5.71	15.31	1.22	1.63	1.84	0.82
hippocampus, adult, donor10258	10374-105G5	63.24	1.49	2.99	5.48	1.49	0.00	4.48	1.00	5.48
hippocampus, newborn, donor10223	10363-105F3	49.35	2.47	3.88	2.47	1.41	1.06	5.64	0.70	8.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4.27	15.26	6.71	0.61	0.61	3.05	1.22	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	4.32	6.68	8.84	0.20	1.57	1.77	0.59	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.06	9.90	7.62	0.51	1.27	1.78	0.51	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	11.84	18.04	9.02	0.00	2.26	2.26	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	13.43	19.62	9.81	0.26	7.23	7.23	0.26	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.18	24.67	4.56	0.00	3.04	6.07	0.00	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	34.16	21.90	8.47	1.75	2.63	4.96	0.29	1.17	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.47	18.53	15.30	2.15	7.32	9.26	0.86	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	28.78	15.01	4.17	0.83	2.92	8.34	0.42	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.13	16.81	3.79	0.95	1.89	8.52	0.71	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.29	15.75	8.52	3.05	4.98	7.07	0.96	0.32	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.24	12.79	4.04	1.35	2.02	6.06	0.67	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.29	9.08	9.55	0.00	1.56	2.35	0.16	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1.47	9.33	6.88	0.00	3.44	0.98	0.00	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4.36	6.98	4.36	0.00	0.87	2.62	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	18.33	20.62	11.07	0.76	9.74	4.96	0.19	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	18.32	21.37	13.08	1.74	5.23	1.74	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	16.49	12.99	4.00	1.00	5.00	2.00	0.00	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	34.29	16.58	11.68	1.13	7.72	3.77	0.19	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.74	12.73	10.00	0.45	8.18	2.73	1.36	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	30.38	11.59	7.20	2.82	3.45	3.76	0.31	0.00	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.27	13.39	6.37	1.63	4.90	9.63	0.49	0.16	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	25.84	12.77	4.06	3.77	1.74	6.39	0.58	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.41	11.36	6.28	0.60	0.90	5.38	0.60	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	7.39	12.19	10.72	0.18	4.06	1.11	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.56	12.55	12.84	0.29	3.14	3.99	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.17	10.62	7.76	0.82	2.86	3.27	0.82	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.14	19.72	7.39	0.70	4.22	4.93	0.70	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.49	15.84	9.82	0.63	8.87	2.22	0.32	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	18.46	16.95	6.96	0.30	3.93	4.54	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.20	16.55	4.65	1.03	6.72	6.72	0.52	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	23.25	13.28	4.65	0.66	1.33	8.63	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	19.50	16.42	3.59	1.28	1.80	6.16	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.43	15.85	3.83	3.58	3.32	6.65	0.26	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.93	12.87	6.82	2.27	2.27	12.12	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.82	9.07	4.03	2.69	2.69	1.68	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.76	10.87	10.63	0.97	2.42	3.62	0.24	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.59	11.14	5.79	0.45	2.67	3.12	0.89	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.32	10.73	12.20	0.00	0.49	2.44	0.49	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.73	26.28	10.39	1.22	8.25	4.28	0.61	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	123.62	3.25	0.00	6.51	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.54	28.46	5.30	0.66	3.97	3.97	0.33	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.34	16.97	9.30	0.55	2.74	6.57	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.71	15.56	9.05	1.09	5.79	3.98	0.72	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	31.32	16.01	6.76	0.71	2.85	5.69	0.00	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	3.58	4.77	0.00	4.77	14.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	31.82	22.35	7.18	1.76	6.09	10.02	0.27	0.27	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	17.24	9.16	4.31	0.81	2.69	4.31	0.27	0.54	0.54
immature langerhans cells, donor1	11904-125F5	16.22	1.45	5.81	6.05	0.48	0.48	0.48	0.00	0.24
immature langerhans cells, donor2	11905-125F6	34.06	11.09	9.51	4.75	3.17	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	102.11	1.42	7.85	12.21	5.87	0.57	3.97	2.27	5.02
keratoacanthoma cell line:HKA-1	10791-110H8	11.71	12.03	7.80	0.65	4.23	5.20	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	29.14	0.70	8.41	4.41	3.70	0.70	0.10	0.60	0.30
kidney, fetal, pool1	10045-101F9	50.72	8.91	16.98	5.31	11.60	4.24	2.33	2.26	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	12.21	10.37	7.39	6.82	2.70	3.98	1.85	1.85	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.99	4.15	3.87	0.83	2.07	1.24	0.14	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	5.32	3.49	4.95	0.37	1.47	1.10	0.55	0.37	0.00
left atrium, adult, donor1	10079-102A7	14.17	0.00	9.81	4.90	3.81	0.00	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	9.10	0.00	6.07	4.55	6.07	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	22.44	9.58	11.22	0.55	4.10	4.10	1.37	1.09	0.82
leiomyoma cell line:10964C	10569-108B2	11.14	4.31	2.16	2.51	0.36	2.51	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	17.39	4.35	2.17	1.63	1.63	1.09	2.72	1.09	0.54
leiomyoma cell line:15425	10571-108B4	10.93	6.80	1.94	1.70	0.97	1.94	0.24	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	5.23	5.23	1.05	2.09	4.18	2.09	2.09	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	12.16	51.24	6.49	6.14	1.65	4.60	0.00	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	21.87	9.06	8.90	2.34	2.19	2.19	1.09	1.09	0.78
liposarcoma cell line:SW 872	10726-110A6	4.75	2.68	4.14	2.19	1.46	0.97	0.24	0.61	0.37
liver, adult, pool1	10018-101C9	9.72	1.13	3.40	2.59	1.78	0.16	0.16	0.32	0.00
liver, fetal, pool1	10086-102B5	4.70	4.70	3.76	0.94	1.88	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	27.42	0.73	9.04	4.23	4.23	0.29	1.60	0.73	1.17
locus coeruleus, adult, donor10252	10165-103B3	29.34	1.29	13.84	3.88	11.44	0.92	0.74	1.48	1.11
locus coeruleus, adult, donor10258	10375-105G6	50.50	0.56	4.51	6.21	3.39	0.00	0.56	0.85	1.41
locus coeruleus, newborn, donor10223	10362-105F2	22.29	2.94	2.52	0.84	2.94	0.42	0.00	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	3.46	3.74	3.46	0.97	0.83	1.25	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	4.14	4.14	3.45	0.00	1.38	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	9.75	4.09	5.80	1.05	1.45	1.98	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	15.36	1.65	7.56	6.38	3.78	0.24	0.47	0.47	0.47
lung, fetal, donor1	10068-101I5	53.37	12.27	6.56	5.14	6.85	2.28	5.42	8.56	3.71
lung, right lower lobe, adult, donor1	10075-102A3	27.95	1.37	14.20	11.00	5.50	0.46	0.00	1.37	0.00
lymph node, adult, donor1	10077-102A5	14.67	0.95	6.63	23.19	1.89	0.00	1.42	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	8.11	3.07	11.40	10.30	2.19	0.44	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	9.06	5.28	10.26	5.13	3.02	1.06	0.91	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	17.84	10.19	1.70	0.85	0.85	4.25	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	14.21	0.44	3.11	0.44	1.78	1.33	0.00	0.89	0.44
mature adipocyte, donor2	12232-129F9	12.04	1.66	2.28	1.45	1.25	0.83	0.21	0.83	0.21
mature adipocyte, donor3	12233-129G1	9.96	1.42	1.90	0.47	1.90	0.24	0.24	0.71	0.00
mature adipocyte, donor4	12234-129G2	22.64	1.84	6.58	1.05	3.69	0.26	1.32	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.36	17.15	15.01	5.00	7.15	9.77	1.19	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	37.23	3.38	7.90	7.90	4.51	0.00	6.77	1.13	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	57.01	3.49	8.64	6.25	9.38	0.55	2.39	1.29	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	59.41	0.00	4.45	2.22	2.86	0.00	4.13	0.95	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	36.68	4.69	2.13	2.56	0.85	1.28	7.25	1.71	4.69
medial temporal gyrus - adult, donor10196	10183-103D3	70.37	1.01	7.76	5.06	3.04	0.51	10.80	2.36	5.74
medial temporal gyrus, adult, donor10252	10156-103A3	54.33	2.55	15.49	6.15	11.88	1.06	2.55	2.97	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	59.71	0.00	0.00	5.78	3.85	0.00	0.00	0.00	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	58.86	1.44	2.51	3.95	2.15	1.79	7.18	0.72	9.33
medulla oblongata - adult, donor10196	10174-103C3	18.82	1.30	4.54	2.60	3.89	0.65	1.30	2.60	1.30
medulla oblongata, adult, donor10252	10155-103A2	32.35	1.70	17.65	3.56	13.78	0.93	0.46	1.55	0.62
medulla oblongata, adult, pool1	10038-101F2	49.71	1.55	9.14	8.73	6.37	0.90	1.06	0.90	1.71
medulla oblongata, newborn, donor10223	10361-105F1	20.14	3.47	3.12	2.78	0.69	1.74	2.08	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	40.30	22.58	21.92	1.77	13.51	9.08	0.89	1.33	0.00
medulloblastoma cell line:ONS-76	10759-110E3	11.25	10.76	4.28	3.30	2.08	1.96	0.49	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	18.83	3.45	7.19	2.87	4.31	1.44	0.86	0.00	0.14
melanoma cell line:G-361	10465-106H6	14.93	2.44	3.26	2.17	2.44	1.09	0.00	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	1.45	2.53	0.90	1.63	0.90	0.72	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	12.34	20.27	14.10	0.88	3.52	14.98	1.76	1.76	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	15.03	18.92	8.04	0.52	1.56	6.74	0.78	0.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.20	7.83	3.38	1.38	1.38	1.07	0.61	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.09	3.82	4.91	2.36	1.45	0.73	1.64	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.31	5.38	2.90	1.66	0.00	0.00	0.41	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.71	2.53	1.55	1.55	1.40	0.42	0.70	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	11.17	2.70	2.31	1.16	1.73	0.39	0.39	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	2.78	1.39	0.69	0.00	1.39	0.69	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.18	3.09	3.43	0.86	0.86	1.20	0.17	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.89	3.57	1.84	0.69	1.84	1.04	0.23	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.74	5.97	2.65	2.39	1.99	0.80	0.27	0.40	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.37	4.19	3.24	3.51	1.35	0.68	0.14	0.27	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.68	6.26	2.56	2.56	2.28	1.28	0.00	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	2.63	4.61	1.98	1.65	1.98	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.93	5.26	2.63	1.52	1.80	0.83	0.28	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.38	3.84	1.75	1.75	0.70	0.70	0.00	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.72	3.47	4.08	1.22	0.82	0.41	0.00	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.41	3.24	6.11	4.31	1.80	0.00	0.00	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.24	3.83	4.55	1.14	2.90	0.72	0.21	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.78	6.84	2.51	2.51	1.14	0.91	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.75	7.13	2.52	1.26	2.10	0.84	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.12	5.53	4.03	1.94	1.34	0.75	0.45	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.64	4.11	3.76	3.24	2.80	0.96	0.26	0.44	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.57	1.84	6.63	0.74	3.68	1.47	0.74	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.17	5.72	4.29	1.43	1.43	1.43	1.14	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	9.26	4.63	1.68	2.11	1.68	0.00	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	2.74	3.20	0.46	1.37	0.00	0.46	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.81	6.39	1.79	1.79	1.02	1.79	2.05	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.99	4.97	4.19	2.36	1.05	1.05	1.31	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.79	4.62	3.39	2.46	0.92	0.31	0.62	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.94	6.35	3.77	1.18	1.18	0.71	1.18	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.52	3.38	4.06	1.35	0.68	1.69	1.35	0.68	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.79	5.89	4.72	1.18	1.18	0.79	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	4.17	1.39	1.85	0.46	0.93	1.85	2.32	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.69	4.61	3.17	1.73	0.58	2.31	1.44	2.02	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.72	3.12	1.78	1.12	1.56	0.45	0.89	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	4.57	4.09	1.92	0.72	0.96	2.40	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	10.27	0.73	1.47	0.00	0.73	1.47	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.10	4.36	3.02	2.01	1.34	1.01	1.34	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	4.09	3.28	3.28	0.41	0.00	1.64	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.03	3.87	1.72	1.72	0.00	0.00	1.29	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	0.00	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.39	3.25	1.30	0.97	1.30	0.65	1.62	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	4.36	1.45	4.36	0.00	1.45	2.91	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.86	3.20	2.67	3.20	1.07	0.00	2.67	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	10.63	2.45	1.64	1.64	0.00	0.82	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	8.94	3.11	1.94	2.33	0.00	0.39	1.17	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	2.10	0.00	2.10	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	6.95	2.98	1.99	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	1.78	3.56	2.96	0.00	0.59	0.59	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	2.44	3.66	0.00	0.00	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	0.63	0.63	3.80	0.63	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.66	2.41	2.07	0.69	0.34	0.34	0.34	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	0.00	0.00	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	6.89	6.89	3.44	6.89	0.00	3.44	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.52	0.81	1.63	1.63	1.22	1.22	0.41	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	2.38	0.79	0.00	1.59	0.00	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	3.54	0.00	1.77	0.00	0.00	0.00	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.86	3.74	2.18	1.56	0.94	0.00	2.18	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	6.68	1.34	0.00	2.67	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	2.37	2.37	2.37	1.18	1.18	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	0.00	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.20	2.07	2.07	2.07	0.00	1.38	1.38	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.91	2.47	2.97	0.00	2.97	1.98	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	5.61	4.49	2.24	2.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.18	3.82	5.72	1.27	0.64	2.54	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.84	2.01	2.42	0.81	1.21	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	2.18	4.36	0.00	0.00	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	1.27	2.53	0.00	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	2.43	1.21	0.00	1.21	1.21	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	6.59	2.47	1.65	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.71	1.39	1.19	0.79	1.79	0.40	0.60	0.60	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.38	0.97	3.57	1.62	0.65	2.27	1.95	0.97	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	4.07	4.07	1.02	1.02	2.04	1.02	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	6.96	5.42	4.64	4.64	1.55	0.00	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	4.25	4.02	3.07	0.24	1.42	0.24	0.47	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	5.79	2.32	2.78	0.46	0.93	0.70	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	4.27	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.06	1.44	1.44	1.23	0.92	0.62	0.21	0.62	0.21
mesothelioma cell line:Mero-25	10850-111F4	9.08	4.09	2.27	2.95	1.13	2.04	0.45	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	8.80	0.49	1.71	1.96	0.73	0.49	0.24	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	12.40	4.43	2.88	2.44	1.11	1.33	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	3.68	4.47	1.84	0.53	1.05	2.10	0.00	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	7.66	4.77	3.74	1.02	1.87	0.17	0.17	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	3.54	1.52	2.02	0.51	0.76	0.25	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	24.22	7.04	6.83	3.52	2.28	1.24	0.21	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	9.44	3.48	2.48	2.82	0.99	0.50	0.00	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	8.87	2.17	2.53	2.71	2.35	0.36	0.54	0.90	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	9.22	3.59	4.78	3.07	2.90	1.02	0.51	0.68	0.00
mesothelioma cell line:NCI-H28	10845-111E8	9.67	8.40	5.34	0.76	1.78	3.82	0.51	0.25	0.76
mesothelioma cell line:No36	10857-111G2	7.50	2.28	2.94	0.65	1.63	0.98	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	5.42	0.81	0.54	1.35	0.54	0.27	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	12.67	5.18	4.03	0.77	1.15	1.73	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	12.46	5.86	4.03	1.59	2.32	2.08	0.00	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	15.97	6.10	3.95	4.31	1.44	0.54	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	8.81	1.96	5.88	0.00	0.98	0.33	0.00	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.30	0.64	3.18	0.64	0.85	0.21	0.00	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	25.80	3.46	13.59	1.38	2.99	0.69	0.69	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.70	5.71	8.75	12.94	1.33	1.90	0.76	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	32.34	4.25	11.83	17.92	4.07	2.40	0.74	0.00	0.37
myeloma cell line:PCM6	10474-106I6	7.51	0.79	3.56	9.09	0.99	1.19	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.10	7.10	7.10	0.00	3.04	4.06	2.03	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	11.96	3.73	5.88	1.57	1.57	0.39	1.37	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.91	5.57	4.46	0.56	1.67	1.11	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.35	6.91	2.50	0.74	0.81	0.66	0.00	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	16.56	5.52	3.31	33.12	1.10	4.97	0.00	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	17.48	15.18	7.36	1.15	6.21	11.50	0.46	1.84	1.61
neuroblastoma cell line:NB-1	10539-107G8	22.45	11.79	20.02	3.37	9.35	5.05	1.68	1.31	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	14.76	8.44	14.76	1.05	5.48	3.37	1.05	0.21	0.63
neuroblastoma cell line:NH-12	10555-107I6	43.98	12.30	35.59	2.24	31.12	5.78	2.05	1.86	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.33	7.35	6.17	3.80	3.80	4.51	4.27	0.95	3.32
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.80	5.07	9.34	1.27	4.28	2.06	0.79	0.16	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	16.70	4.43	6.44	0.40	1.61	2.21	0.60	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	11.44	3.81	4.45	1.91	0.00	0.64	0.64	0.64	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	10.11	2.13	3.99	2.93	0.53	0.80	1.33	0.27	0.27
neutrophil PMN, donor1	12133-128D9	44.62	44.62	0.00	312.37	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	92.96	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	94.71	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	5.92	25.03	11.67	7.27	4.06	7.27	0.85	1.01	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	5.60	8.01	0.00	4.00	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.44	6.73	4.81	2.24	3.53	5.13	3.85	4.17	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.58	3.42	4.47	1.31	3.42	0.79	0.00	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	84.08	4.12	8.06	8.53	7.31	1.31	4.31	0.94	4.12
occipital cortex - adult, donor10196	10172-103C1	53.57	0.00	12.36	12.36	0.00	0.00	4.12	6.18	8.24
occipital cortex, adult, donor10252	10163-103B1	48.84	0.81	23.62	4.56	17.98	0.54	1.61	1.07	2.15
occipital cortex, newborn, donor10223	10355-105E4	70.97	2.55	5.10	5.46	2.55	0.73	5.82	0.73	9.83
occipital lobe, adult, donor1	10076-102A4	84.49	0.52	12.07	11.28	5.51	0.26	8.40	3.15	5.51
occipital lobe, fetal, donor1	10073-102A1	117.14	6.87	20.60	7.29	6.44	10.30	16.31	5.15	15.45
occipital pole, adult, pool1	10036-101E9	90.35	1.66	6.31	10.49	5.36	0.87	4.81	1.26	3.47
olfactory region, adult	10195-103E6	55.60	1.53	7.45	5.92	6.30	0.57	1.53	0.57	1.15
optic nerve, donor1	10277-104E7	64.03	4.00	14.01	10.01	2.00	0.00	0.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.00	19.48	6.61	0.68	1.14	8.09	0.11	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.22	8.24	4.95	0.14	2.20	1.24	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.62	14.90	3.73	0.51	1.19	5.08	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	4.39	7.16	2.31	0.58	0.81	2.43	0.12	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	5.29	4.41	3.53	1.18	0.29	0.88	0.88	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1.87	10.28	1.87	3.74	0.93	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.90	9.54	14.84	1.27	8.69	3.39	2.54	1.48	1.70
ovary, adult, pool1	10020-101D2	43.06	2.71	8.65	3.41	5.94	2.01	1.92	3.49	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.42	1.65	3.67	1.83	0.92	0.18	0.18	0.18	0.18
pancreas, adult, donor1	10049-101G4	17.87	2.82	13.17	0.94	2.82	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.19	4.47	6.71	0.00	0.84	2.24	0.00	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	11.07	3.24	3.07	3.75	1.36	1.36	0.85	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.44	8.61	5.46	0.99	3.31	2.81	0.00	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	68.18	1.74	6.32	7.05	5.40	0.73	3.11	1.28	3.94
parietal cortex, adult, donor10258	10373-105G4	51.38	2.20	3.67	13.95	0.00	0.00	2.94	0.73	2.94
parietal lobe - adult, donor10196	10171-103B9	33.86	0.94	6.58	5.64	3.76	0.00	4.70	1.88	6.58
parietal lobe, adult, donor10252	10157-103A4	47.89	1.43	11.69	4.56	7.98	0.86	2.00	3.14	2.85
parietal lobe, adult, pool1	10034-101E7	68.65	1.94	7.23	6.87	6.17	0.97	2.64	1.23	4.32
parietal lobe, fetal, donor1	10072-101I9	80.50	3.88	20.37	5.82	8.73	8.73	9.70	9.70	33.94
parietal lobe, newborn, donor10223	10356-105E5	67.29	3.36	2.62	4.86	1.50	2.24	7.48	2.24	7.10
parotid gland, adult	10199-103F1	42.55	3.70	13.57	9.25	4.32	0.00	0.00	1.85	0.00
penis, adult	10200-103F2	29.54	3.22	10.21	4.30	5.91	2.15	0.00	4.30	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	9.11	4.09	2.79	2.60	1.86	1.12	0.56	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	6.12	4.81	4.95	0.29	1.60	1.46	0.00	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	26.45	8.39	5.81	1.29	3.23	2.58	3.87	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	57.44	12.44	21.91	5.33	12.44	8.29	2.96	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	74.62	8.15	7.52	6.27	3.76	3.76	1.25	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	20.24	7.08	11.13	0.00	4.05	3.04	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	41.69	14.59	23.45	3.13	14.59	6.78	1.04	3.65	0.52
pituitary gland, adult, donor10258	10378-105G9	77.46	1.70	19.58	0.85	7.66	0.85	0.00	1.70	1.70
placenta, adult, pool1	10021-101D3	18.49	5.16	11.83	6.77	5.38	3.23	0.43	0.75	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	11.12	5.43	5.83	7.02	1.59	0.66	0.66	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.28	6.07	11.98	2.33	5.60	2.33	1.71	0.78	0.93
pons, adult, pool1	10033-101E6	50.69	0.95	5.08	6.37	5.08	0.60	1.29	0.26	1.55
postcentral gyrus, adult, pool1	10032-101E5	84.65	2.09	7.24	8.72	4.71	0.87	5.23	2.35	5.23
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	50.19	10.46	62.74	4.18	23.01	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	5.51	27.54	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.45	4.22	10.05	0.73	4.95	1.31	0.00	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	7.62	4.17	4.36	0.91	2.90	1.27	0.73	0.18	0.00
prostate, adult, pool1	10022-101D4	41.63	3.17	13.06	3.99	10.61	1.72	2.09	2.45	1.00
putamen, adult, donor10196	10176-103C5	67.28	6.37	12.04	6.37	8.97	2.36	8.97	0.47	6.61
putamen, adult, donor10252	10152-102I8	56.86	1.96	7.84	3.92	0.00	1.96	0.00	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	7.65	3.28	3.28	0.00	0.00	2.19	1.09	8.74
putamen, adult, donor10258, tech_rep2	10372-105G3	71.03	3.62	5.56	5.07	3.62	0.72	6.52	1.21	8.94
putamen, newborn, donor10223	10365-105F5	29.24	2.25	1.50	1.50	3.00	0.75	10.50	0.00	9.75
rectal cancer cell line:TT1TKB	10469-106I1	5.53	7.56	4.07	0.58	0.87	4.36	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	34.77	4.17	31.99	11.13	9.74	5.56	2.78	8.35	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	17.38	2.12	3.82	1.91	3.18	0.42	0.64	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.07	4.56	4.56	0.83	1.66	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	83.99	1.89	24.75	10.74	14.31	1.29	2.09	3.68	2.19
retinoblastoma cell line:Y79	10475-106I7	12.99	15.33	9.61	0.52	9.61	5.20	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	25.33	12.42	16.72	1.60	3.07	2.21	2.09	1.23	1.72
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	17.15	10.40	16.87	1.41	9.56	2.81	0.84	1.97	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	8.34	5.30	1.52	0.76	6.06	2.27	4.55	0.76
salivary acinar cells, donor1	11771-123I7	13.92	13.60	5.34	1.13	2.27	2.10	0.00	0.00	0.16
salivary acinar cells, donor2	11772-123I8	28.64	24.23	8.95	2.75	6.47	6.47	0.28	0.14	0.00
salivary acinar cells, donor3	11773-123I9	14.57	26.48	11.92	1.99	3.97	3.97	1.99	0.66	0.00
salivary gland, adult, pool1	10093-102C3	56.62	4.58	9.15	9.72	12.58	0.00	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.18	3.37	3.54	3.37	1.35	1.10	0.67	0.34	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.23	3.41	4.35	4.00	2.23	1.53	0.59	0.24	0.35
seminal vesicle, adult	10201-103F3	77.77	1.59	17.46	10.58	13.76	0.53	1.06	3.17	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.59	4.62	4.86	0.49	2.19	2.67	0.73	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	3.02	2.52	3.02	0.25	1.51	1.01	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	2.01	0.00	0.00	0.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.98	8.19	5.91	0.27	1.48	2.15	0.27	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	10.94	3.09	2.76	0.88	0.66	0.33	0.33	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	4.52	3.10	3.35	0.65	1.29	0.39	0.00	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	1.42	7.80	2.13	1.42	0.00	3.55	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	26.51	0.84	11.15	4.92	4.44	0.12	0.96	0.72	0.24
skeletal muscle, fetal, donor1	10066-101I3	35.18	6.03	9.05	9.05	4.02	1.01	2.01	4.02	5.03
skin, adult, donor1	10074-102A2	54.28	13.57	27.14	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	26.51	8.84	20.83	4.42	5.68	4.42	3.79	3.16	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	6.67	5.00	8.34	0.00	3.34	0.33	0.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.53	34.67	27.74	1.26	9.46	11.66	3.47	3.47	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	17.54	24.29	7.52	2.31	3.66	2.89	3.28	1.16	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	3.63	7.75	2.97	0.00	1.65	1.98	0.16	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	7.40	8.85	9.97	0.00	7.08	1.29	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	13.29	8.28	10.46	2.83	5.67	1.74	0.87	0.44	0.00
small intestine, adult, pool1	10024-101D6	24.72	2.87	6.93	4.78	4.06	0.72	0.84	0.24	0.36
small intestine, fetal, donor1	10064-101I1	25.06	2.95	14.00	6.39	3.44	1.72	1.47	2.21	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	20.00	2.05	10.26	4.10	3.08	2.56	0.51	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	38.77	2.07	18.61	4.14	14.73	0.26	1.55	3.36	2.07
somatostatinoma cell line:QGP-1	10781-110G7	9.92	8.84	9.11	2.41	2.41	2.95	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	29.59	1.38	10.09	4.36	4.82	0.00	2.29	1.15	1.61
spinal cord, adult, donor10252	10159-103A6	26.81	1.18	14.19	5.13	11.83	1.18	0.79	0.79	2.37
spinal cord, adult, donor10258	10369-105F9	22.83	1.38	1.38	2.77	0.00	0.00	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	39.64	6.71	15.25	6.71	6.71	3.66	2.44	2.44	2.44
spinal cord, newborn, donor10223	10359-105E8	28.47	1.84	1.84	1.38	0.46	1.84	0.46	0.92	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.71	3.29	3.88	2.09	1.49	0.45	0.45	0.30	0.60
spleen, adult, pool1	10025-101D7	19.38	2.64	6.50	19.93	3.74	0.99	0.88	0.55	0.44
spleen, fetal, pool1	10044-101F8	28.29	9.38	10.49	21.29	6.52	2.22	1.43	1.35	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	9.73	23.29	6.31	2.79	2.07	5.38	0.72	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	3.23	3.61	2.85	0.19	0.95	1.52	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	42.98	5.94	11.18	1.75	3.49	2.80	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	3.52	10.16	2.35	0.78	0.00	0.78	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	14.52	5.97	3.26	1.24	1.58	1.46	0.23	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	4.66	2.54	0.42	3.39	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.92	1.69	4.65	0.42	0.85	1.27	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	20.29	3.20	18.16	12.82	4.27	1.07	5.34	3.20	3.20
submaxillary gland, adult	10202-103F4	56.97	1.14	13.10	14.24	9.68	0.57	1.14	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	36.56	1.45	14.33	4.57	17.66	0.42	0.42	1.66	0.83
substantia nigra, adult, donor10258	10371-105G2	30.00	1.55	4.14	3.10	2.07	0.52	0.52	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	24.73	1.41	0.71	2.12	0.00	0.71	0.00	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	66.03	13.99	16.28	6.65	8.71	3.67	4.36	2.06	5.04
temporal lobe, adult, pool1	10031-101E4	96.64	2.12	7.88	10.43	6.36	0.85	3.39	1.95	3.81
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	99.72	7.83	17.09	9.97	12.11	8.55	10.68	4.27	12.11
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	101.97	16.70	14.50	10.55	4.83	14.07	5.27	2.20	10.99
tenocyte, donor1	11763-123H8	12.57	6.63	2.44	3.49	1.75	0.70	0.00	0.35	0.70
tenocyte, donor2	11765-123I1	22.89	3.82	4.58	2.29	1.53	1.53	1.91	2.29	0.00
tenocyte, donor3	11768-123I4	12.60	4.82	2.97	2.22	1.11	1.48	0.37	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	5.95	8.33	8.16	0.51	2.72	2.89	0.17	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	14.03	9.56	16.96	0.46	6.94	2.77	0.31	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	7.28	5.73	16.12	0.00	2.94	1.24	0.31	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	4.57	7.62	9.52	0.51	2.41	2.54	0.51	0.51	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	11.72	10.59	12.48	1.13	3.78	3.03	0.00	0.38	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	8.07	9.82	27.37	0.87	8.40	1.96	0.76	0.44	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.33	9.77	10.75	0.65	1.30	4.56	0.33	0.33	0.00
testis, adult, pool1	10026-101D8	23.73	14.82	5.05	4.83	3.65	2.36	1.40	2.04	0.97
testis, adult, pool2	10096-102C6	26.16	24.36	9.02	4.51	4.51	4.06	1.80	3.61	1.35
thalamus - adult, donor10196	10168-103B6	30.91	0.00	5.52	3.31	2.21	0.00	2.21	0.00	1.10
thalamus, adult, donor10252	10154-103A1	49.70	2.03	14.07	3.13	20.63	0.94	0.31	1.25	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	50.81	0.00	6.16	6.16	1.54	0.00	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	35.08	0.66	3.29	4.45	2.64	0.16	1.32	0.66	0.99
thalamus, newborn, donor10223	10366-105F6	13.23	1.15	0.00	0.58	0.58	0.00	1.15	0.58	1.73
throat, adult	10209-103G2	33.71	7.99	5.74	7.74	4.99	1.25	1.00	2.50	1.75
throat, fetal, donor1	10061-101H7	35.04	4.88	14.32	5.48	5.79	2.74	1.83	1.52	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	45.91	12.12	13.51	1.39	6.96	1.99	3.38	2.19	2.58
thymus, adult, pool1	10027-101D9	26.54	19.58	3.68	20.58	1.59	10.24	2.39	3.18	4.47
thymus, fetal, pool1	10043-101F7	31.28	28.89	5.82	27.02	4.16	8.52	4.05	3.43	4.88
thyroid carcinoma cell line:KHM-5M	10776-110G2	10.50	3.72	3.06	2.26	1.60	0.40	0.13	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	15.37	2.51	7.68	5.17	4.05	0.70	0.28	0.14	0.14
thyroid, adult, pool1	10028-101E1	35.27	0.56	15.68	2.05	9.89	0.56	1.12	1.59	0.37
thyroid, fetal, donor1	10060-101H6	44.03	1.32	16.08	5.01	5.54	0.53	0.53	1.32	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	30.80	52.35	3.08	15.40	0.00	9.24	3.08	3.08
tongue, adult	10203-103F5	30.24	6.28	6.74	4.19	5.35	0.93	0.93	1.16	1.16
tongue, fetal, donor1	10059-101H5	16.55	2.76	7.09	3.94	2.76	1.97	2.36	2.36	0.79
tonsil, adult, pool1	10047-101G2	41.37	13.02	12.82	27.55	5.81	2.50	1.20	0.90	0.60
trachea, adult, pool1	10029-101E2	19.80	4.83	6.63	5.40	4.50	1.39	0.49	0.16	0.33
trachea, fetal, donor1	10058-101H4	24.24	3.85	13.46	2.31	3.85	1.15	0.77	2.31	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.63	4.25	4.25	1.77	1.77	0.71	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	8.71	8.81	3.65	0.41	1.11	2.63	0.10	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	7.05	4.54	10.03	1.41	1.72	2.51	0.16	0.16	0.00
tridermal teratoma cell line:HGRT	10694-109G1	11.42	26.64	3.81	3.81	0.00	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.39	5.84	2.29	0.68	1.19	1.69	0.00	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	29.21	4.17	0.00	2.09	6.26	0.00	2.09	4.17	4.17
uterus, adult, pool1	10100-102D1	58.87	3.24	11.94	6.83	9.56	1.71	3.92	5.80	2.56
uterus, fetal, donor1	10055-101H1	27.13	6.14	13.31	5.12	5.63	3.58	5.12	4.61	1.02
vagina, adult	10204-103F6	10.99	1.94	12.28	3.88	6.46	1.94	1.29	1.29	0.00
vein, adult	10191-103E2	30.25	2.63	7.89	17.97	4.16	0.66	1.53	1.32	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.01	5.07	5.87	4.54	0.80	0.80	0.27	0.00	0.00